Isotonic versus hypotonic solutions for maintenance intravenous fluid administration in children by McNab, Sarah et al.
Cochrane Database of Systematic Reviews
Isotonic versus hypotonic solutions for maintenance
intravenous fluid administration in children (Review)
McNab S, Ware RS, Neville KA, Choong K, Coulthard MG, Duke T, Davidson A, Dorofaeff T
McNab S, Ware RS, Neville KA, Choong K, Coulthard MG, Duke T, Davidson A, Dorofaeff T.
Isotonic versus hypotonic solutions for maintenance intravenous fluid administration in children.
Cochrane Database of Systematic Reviews 2014, Issue 12. Art. No.: CD009457.
DOI: 10.1002/14651858.CD009457.pub2.
www.cochranelibrary.com
Isotonic versus hypotonic solutions for maintenance intravenous fluid administration in children (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
T A B L E O F C O N T E N T S
1HEADER . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
1ABSTRACT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
2PLAIN LANGUAGE SUMMARY . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
3SUMMARY OF FINDINGS FOR THE MAIN COMPARISON . . . . . . . . . . . . . . . . . . .
6BACKGROUND . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6OBJECTIVES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
6METHODS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
9RESULTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Figure 1. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 10
16DISCUSSION . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
18AUTHORS’ CONCLUSIONS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
18ACKNOWLEDGEMENTS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
18REFERENCES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
20CHARACTERISTICS OF STUDIES . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
33DATA AND ANALYSES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
Analysis 1.1. Comparison 1 Isotonic versus hypotonic, Outcome 1 Hyponatraemia. . . . . . . . . . . . . 34
Analysis 1.2. Comparison 1 Isotonic versus hypotonic, Outcome 2 Hypernatraemia. . . . . . . . . . . . 35
Analysis 1.3. Comparison 1 Isotonic versus hypotonic, Outcome 3 Mean serum sodium T6-T12. . . . . . . . 36
Analysis 1.4. Comparison 1 Isotonic versus hypotonic, Outcome 4 Mean serum sodium at T > T12 to T24. . . . 37
Analysis 1.5. Comparison 1 Isotonic versus hypotonic, Outcome 5 Death. . . . . . . . . . . . . . . . 38
Analysis 1.6. Comparison 1 Isotonic versus hypotonic, Outcome 6 Seizures. . . . . . . . . . . . . . . 39
Analysis 1.7. Comparison 1 Isotonic versus hypotonic, Outcome 7 Cerebral oedema. . . . . . . . . . . . 40
Analysis 1.8. Comparison 1 Isotonic versus hypotonic, Outcome 8 Overhydration. . . . . . . . . . . . . 41
Analysis 1.9. Comparison 1 Isotonic versus hypotonic, Outcome 9 Urine osmolarity at T24. . . . . . . . . . 42
Analysis 1.10. Comparison 1 Isotonic versus hypotonic, Outcome 10 Urinary sodium concentration at T24. . . . 43
Analysis 1.11. Comparison 1 Isotonic versus hypotonic, Outcome 11 Hyponatraemia (by concentration of hypotonic
fluid). . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
Analysis 1.12. Comparison 1 Isotonic versus hypotonic, Outcome 12 Hyponatraemia (surgical/medical). . . . . 45
Analysis 1.13. Comparison 1 Isotonic versus hypotonic, Outcome 13 Hyponatraemia (by fluid rate). . . . . . . 46
Analysis 1.14. Comparison 1 Isotonic versus hypotonic, Outcome 14 Hyponatraemia (by age). . . . . . . . . 47
Analysis 1.15. Comparison 1 Isotonic versus hypotonic, Outcome 15 Hyponatraemia (by severity of illness). . . . 48
Analysis 1.16. Comparison 1 Isotonic versus hypotonic, Outcome 16 Sensitivity analysis - balanced fluid rates. . . 50
Analysis 1.17. Comparison 1 Isotonic versus hypotonic, Outcome 17 Sensitivity analysis - normonatraemic at baseline. 51
51ADDITIONAL TABLES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
57APPENDICES . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
59CONTRIBUTIONS OF AUTHORS . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
59DECLARATIONS OF INTEREST . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
59SOURCES OF SUPPORT . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
59DIFFERENCES BETWEEN PROTOCOL AND REVIEW . . . . . . . . . . . . . . . . . . . . .
60INDEX TERMS . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .
iIsotonic versus hypotonic solutions for maintenance intravenous fluid administration in children (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
[Intervention Review]
Isotonic versus hypotonic solutions for maintenance
intravenous fluid administration in children
Sarah McNab1, Robert S Ware2,3, Kristen A Neville4, Karen Choong5, Mark G Coulthard6,7, Trevor Duke8, Andrew Davidson9 ,
Tavey Dorofaeff7
1c/o Centre for International Child Health, Royal Children’s Hospital, Parkville, Australia. 2School of Population Health, The Uni-
versity of Queensland, Brisbane, Australia. 3Queensland Children’s Medical Research Institute, The University of Queensland, Bris-
bane, Australia. 4Sydney Children’s Hospital, Randwick, Australia. 5Department of Pediatrics and Critical Care Medicine, McMaster
University, Hamilton, Canada. 6Queensland Children’s Medical Research Institute, Royal Children’s Hospital, Brisbane, Australia.
7Paediatric Intensive Care Unit, Royal Children’s Hospital, Brisbane, Australia. 8Paediatrics, Royal Children’s Hospital, Melbourne,
Australia. 9Department of Anaesthetics, Royal Children’s Hospital, Parkville, Australia
Contact address: Sarah McNab, c/o Centre for International Child Health, Royal Children’s Hospital, Flemington Rd, Parkville, VIC,
3052, Australia. Sarah.McNab@rch.org.au.
Editorial group: Cochrane Injuries Group.
Publication status and date: New, published in Issue 12, 2014.
Review content assessed as up-to-date: 17 June 2013.
Citation: McNab S, Ware RS, Neville KA, Choong K, Coulthard MG, Duke T, Davidson A, Dorofaeff T. Isotonic versus hypotonic
solutions for maintenance intravenous fluid administration in children. Cochrane Database of Systematic Reviews 2014, Issue 12. Art.
No.: CD009457. DOI: 10.1002/14651858.CD009457.pub2.
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
A B S T R A C T
Background
Maintenance intravenous fluids are frequently used in hospitalised children who cannot maintain adequate hydration through enteral
intake. Traditionally used hypotonic fluids have been associated with hyponatraemia and subsequent morbidity and mortality. Use of
isotonic fluid has been proposed to reduce complications.
Objectives
To establish and compare the risk of hyponatraemia by systematically reviewing studies where isotonic is compared with hypotonic
intravenous fluid for maintenance purposes in children.
Secondly, to compare the risk of hypernatraemia, the effect on mean serum sodium concentration and the rate of attributable adverse
effects of both fluid types in children.
Search methods
We ran the search on 17 June 2013. We searched the Cochrane Injuries Group Specialised Register, Cochrane Central Register of
Controlled Trials (CENTRAL, The Cochrane Library), MEDLINE (OvidSP), Embase (OvidSP), and ISI Web of Science. We also
searched clinical trials registers and screened reference lists. We updated this search in October 2014 but these results have not yet been
incorporated.
Selection criteria
We included randomised controlled trials that compared isotonic versus hypotonic intravenous fluids for maintenance hydration in
children.
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Data collection and analysis
At least two authors assessed and extracted data for each trial. We presented dichotomous outcomes as risk ratios (RR) with 95%
confidence intervals (CIs) and continuous outcomes as mean differences with 95% CIs.
Main results
Ten studies met the inclusion criteria, with a total of 1106 patients. The majority of the studies were performed in surgical or intensive
care populations (or both). There was considerable variation in the composition of intravenous fluid, particularly hypotonic fluid, used
in the studies. There was a low risk of bias for most of the included studies. Ten studies provided data for our primary outcome, a
total of 449 patients in the analysis received isotonic fluid, while 521 received hypotonic fluid. Those who received isotonic fluid had
a substantially lower risk of hyponatraemia (17% versus 34%; RR 0.48; 95% CI 0.38 to 0.60, high quality evidence). It is unclear
whether there is an increased risk of hypernatraemia when isotonic fluids are used (4% versus 3%; RR 1.24; 95% CI 0.65 to 2.38, nine
studies, 937 participants, low quality evidence), although the absolute number of patients developing hypernatraemia was low. Most
studies had safety restrictions included in their methodology, preventing detailed investigation of serious adverse events.
Authors’ conclusions
Isotonic intravenous maintenance fluids with sodium concentrations similar to that of plasma reduce the risk of hyponatraemia when
compared with hypotonic intravenous fluids. These results apply for the first 24 hours of administration in a wide group of primarily
surgical paediatric patients with varying severities of illness.
P L A I N L A N G U A G E S U M M A R Y
Fluids for hydration in children
Background
Many children in hospital need fluid through an intravenous line (or ’drip’) because they cannot eat or drink enough and they need to
remain hydrated. This fluid can cause rare but serious side effects due to the salt level in the body decreasing. When the salt level in the
body decreases quickly brain swelling can occur, which can result in death.
There has been uncertainty regarding how much salt the intravenous fluid should contain.
Review question
Traditionally, fluids containing lower salt levels than blood (hypotonic) have been administered. This analysis compared these fluids
with fluid containing a similar salt level to blood (isotonic). We aimed to determine how many patients had low salt levels in the blood
when an isotonic fluid was used compared with a hypotonic fluid.
Key results
Studies conducted prior to 17 June 2013 were reviewed. We included 10 studies in the analysis, involving a total of 1106 children.
When isotonic fluids were used, the sodium level in the body was less likely to be low. One hundred and sixty-nine children per 1000
had low sodium levels in the blood when an isotonic fluid was given, compared with 338 children per 1000 when a hypotonic fluid
was used. The results for serious adverse events associated with isotonic or hypotonic fluids were uncertain.
This review mainly looked at patients who either had surgery and/or were in intensive care, with most only needing intravenous fluid
for less than a day.
Quality of the evidence
The studies included were generally well conducted and were of a high quality.
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S U M M A R Y O F F I N D I N G S F O R T H E M A I N C O M P A R I S O N [Explanation]
Isotonic intravenous fluid compared with hypotonic intravenous fluid to maintain hydration
Patient or population: children requiring intravenous f luid to maintain hydrat ion
Settings: inpat ient hospital sett ing
Intervention: isotonic intravenous f luid
Comparison: hypotonic intravenous f luid
Outcomes Illustrative comparative risks* (95% CI) Relative effect
(95% CI)
No of participants
(studies)
Quality of the evidence
(GRADE)
Comments
Assumed risk Corresponding risk
Hypotonic intravenous
fluid
Isotonic intravenous
fluid
Hyponatraemia (serum
sodium < 135 mmol/ L)
Study populat ion RR 0.48 (0.38 to 0.60) 970
(10)
⊕⊕⊕⊕
high
338 per 1000 169 per 1000
(134 to 211)
Surgical pat ients RR 0.48 (0.36 to 0.64) 529
(7)
⊕⊕⊕⊕
high
379 per 1000 185 per 1000
(139 to 247)
Medical pat ients RR 0.29 (0.16 to 0.55) 279
(4)
⊕⊕⊕©
moderate
276 per 1000 83 per 1000
(46 to 157)
Intensive care pat ients RR 0.48 (0.37 to 0.64) 443
(5)
⊕⊕⊕⊕
high
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446 per 1000 217 per 1000
(167 to 289)
Non-intensive care pat ients RR 0.45 (0.29 to 0.68) 359
(5)
⊕⊕⊕©
moderate
312 per 1000 135 per 1000
(87 to 204)
Hypernatraemia Study populat ion RR 1.24 (0.65 to 2.38) 937
(9)
⊕⊕©©
low
Quality of evidence
downgraded due to im-
precision - small num-
ber of events, wide con-
f idence interval
34 per 1000 37 per 1000
(19 to 71)
Death Study populat ion 5.59 (0.23 to 135.17) 996
(10)
⊕⊕©©
low
Quality of evidence
downgraded due to im-
precision - small num-
ber of events, wide con-
f idence interval
Study design reduced
the likelihood of this
outcome
0 per 1000 2 per 1000
(0 to 48)
Seizures Study populat ion RR 0.62 (0.03 to 15.02) 996
(10)
⊕⊕©©
low
Quality of evidence
downgraded due to im-
precision - small num-
ber of events, wide con-
f idence interval
Study design reduced
the likelihood of this
outcome2 per 1000 0 per 1000
Cerebral oedema Study populat ion RR incalculable 9 studies ⊕©©©
very low
Quality of evidence
downgraded due to im-
precision - no events, in-
calculable conf idence
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interval
Study design reduced
the likelihood of this
outcome
0 per 1000 0 per 1000
Overhydration Study populat ion RR 1.14 (0.46 to 2.87) 615
(5)
⊕⊕©©
low
Quality of evidence
downgraded due to im-
precision - small num-
ber of events, wide con-
f idence interval
Heterogeneity in the cri-
teria for assessing this
outcome
26 per 1000 30 per 1000
(12 to 76)
* The basis for the assumed risk (e.g. the median control group risk across studies) is provided in footnotes. The corresponding risk (and its 95% conf idence interval) is
based on the assumed risk in the comparison group and the relative effect of the intervent ion (and its 95% CI).
CI: conf idence interval; RR: risk rat io
GRADE Working Group grades of evidence
High quality: Further research is very unlikely to change our conf idence in the est imate of ef fect.
M oderate quality: Further research is likely to have an important impact on our conf idence in the est imate of ef fect and may change the est imate.
Low quality: Further research is very likely to have an important impact on our conf idence in the est imate of ef fect and is likely to change the est imate.
Very low quality: We are very uncertain about the est imate.
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B A C K G R O U N D
Maintenance intravenous fluids are frequently used in hospitalised
childrenwho cannotmaintain adequate hydration through enteral
intake.
Traditionally, hypotonic fluids, containing approximately 30 to
50 mmol/L of sodium, have been prescribed for maintenance hy-
dration. Fluid of this composition, prescribed at standard main-
tenance rates, provides approximately 2 to 4 mmol/kg of sodium
each day. This is consistent with requirements described in a land-
mark paper published in 1957 examining maintenance fluid re-
quirements in children (Holliday 1957). However, this fluid is
markedly hypotonic when compared with plasma, which contains
approximately 140 mmol/L of sodium. It has been postulated that
this may lead to hyponatraemia and cerebral oedema, which has
significant neurological morbidity.
There are a number of case series reporting deaths secondary
to hyponatraemia in association with maintenance intravenous
fluid (Arieff 1992; Halberthal 2001; Hoorn 2004; Hughes 1998;
Koczmara 2010;Moritz 2005). It has been proposed that using an
isotonic maintenance intravenous fluid may reduce complications
secondary to hyponatraemia.
Description of the condition
Maintenance volumes of hypotonic fluid have previously been
considered safe in most children due to the adaptive mechanisms
of the kidney, which enable the excretion of excess free water and
thus the maintenance of sodium balance. However, increased lev-
els of circulating antidiuretic hormone are more common in hos-
pitalised children than previously appreciated (Moritz 2003), de-
creasing their ability to excrete excess water and placing them at
risk of hyponatraemia. Osmotic fluid shifts from the extracellular
to intracellular space secondary to hyponatraemia can cause cere-
bral oedema, which can result in significant irreversible neurolog-
ical morbidity and death.
Description of the intervention
When describing a fluid as hypotonic, isotonic or hypertonic, we
are referring to the in vivo tonicity. Given that dextrosemetabolises
rapidly to free water, the in vivo tonicity of fluids containing dex-
trose differs from the in vitro tonicity or osmolarity. The in vitro
osmolarity refers to the number of osmoles of solute per litre of
solution, while the in vivo tonicity is the total concentration of so-
lutes available to exert an osmotic force across the cell membrane.
In practice, an isotonic fluid is one containing a similar concen-
tration of sodium to plasma, while a hypotonic fluid contains less
sodium than plasma.
Maintenance volume refers to the fluid required to maintain ade-
quate hydration in a child who is not eating and drinking but who
is otherwise euvolaemic. It is the volume required for the kidneys
to excrete excess solute load in an isotonic urine and replace in-
sensible losses.
How the intervention might work
An isotonic fluid is considered physiologic as it has a similar
sodium concentration to the extracellular space into which it is
being administered. By using an isotonic rather than a hypotonic
fluid, it is anticipated that there will be less likelihood of hypona-
traemia and, therefore, the osmotic difference between the extra-
cellular and intracellular spaces will be minimised. This should
lessen the fluid shifts between compartments and reduce the risk
of cerebral oedema.
While an isotonic fluid could still potentially result in hypona-
traemia in the context of impaired urinary dilution, it is antici-
pated that the likelihood of this will be markedly diminished.
Why it is important to do this review
Intravenous fluid therapy is one of themost common interventions
for hospitalised children. There is currently no clear consensus
on the optimal composition of maintenance intravenous therapy,
leading to wide practice variation (Davies 2008; Freeman 2012;
Way 2006).
Children are still dying or suffering significant morbidity due to
hyponatraemia associated with intravenous fluid administration.
If an isotonic fluid is found to be superior in terms of clinically
significant hyponatraemia, there will be a strong argument to shift
routine maintenance fluid to the higher sodium-containing solu-
tions. This shift in the default for fluid therapy will alter therapy
for millions of children worldwide, potentially saving lives and
reducing morbidity.
O B J E C T I V E S
To establish and compare the risk of hyponatraemia by systemati-
cally reviewing studies where isotonic is compared with hypotonic
intravenous fluid for maintenance purposes in children.
Secondly, to compare the risk of hypernatraemia, the effect on
mean serum sodium concentration and the rate of attributable
adverse effects of both fluid types in children.
M E T H O D S
Criteria for considering studies for this review
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Types of studies
We included randomised controlled trials (RCTs) that compared
isotonic or near isotonic (sodium ≥ 125 to 160 mmol/L) versus
hypotonic (sodium < 125 mmol/L) intravenous fluids for main-
tenance hydration in children.
Blinding was not a requisite for inclusion.
Types of participants
We included trials where themajority of participants were children
(aged three months to 18 years) who required intravenous fluids
for maintenance hydration.
We did not include or exclude studies on the basis of any specific
medical diagnoses examined.
Types of interventions
The intervention group were patients who received isotonic or
near isotonic fluid (a fluid with a sodium concentration approx-
imately equal to that of human plasma). The comparison group
were patients who received hypotonic fluid (a fluid with a sodium
concentration less than that of human plasma).
For the purposes of the review, we considered fluids with a sodium
concentration ≥ 125 to 160 mmol/L isotonic or near isotonic,
while we considered those with a sodium concentration < 125
mmol/L hypotonic. When determining these ranges, we took into
account the normal serum sodium range (135 to 145 mmol/L)
and the sodium concentration of commercially available, com-
monly used fluids (see Table 1 - ’Common commercially available
intravenous fluids’).
We only included studies where the fluid was primarily admin-
istered for maintenance hydration (that is, not for resuscitation
purposes or to replace a pre-existing deficit).
Types of outcome measures
Primary outcomes
The primary outcome was the proportion of participants in each
treatment groupwith hyponatraemia (serum sodium<135mmol/
L) at any time point while receiving intravenous fluids.
Each participant was counted only once, despite the number of
hyponatraemic events he or she had.
Secondary outcomes
Other outcomes of interest were:
• the proportion of participants in each treatment group who
developed hypernatraemia (serum sodium > 145 mmol/L) while
receiving intravenous fluids;
• mean serum sodium;
• adverse clinical effects including:
◦ death;
◦ seizures;
◦ cerebral oedema;
◦ overhydration (author defined clinical assessment);
• antidiuretic hormone levels.
• urinary osmolarity and electrolytes.
Search methods for identification of studies
In order to reduce publication and retrieval bias we did not restrict
our search by language, date or publication status.
Electronic searches
We searched the following:
• Cochrane Injuries Group Specialised Register (9 May
2013);
• Cochrane Central Register of Controlled Trials
(CENTRAL,The Cochrane Library, issue 4 of 12 2013);
• MEDLINE (OvidSP) (1946 to June, week 4 2013);
• Embase (OvidSP) (1974 to 2013 week 27);
• ISI Web of Science: Science Citation Index Expanded (SCI-
EXPANDED) (1970 to 17 June 2013);
• ISI Web of Science: Conference Proceedings Citation
Index-Science (CPCI-S) (1990 to 17 June 2013).
Search strategies are reported in (Appendix 1). We adapted the
MEDLINE search strategy as necessary for each of the other
databases: the added study filter is theOvidMEDLINECochrane
Highly Sensitive Search Strategy for identifying randomised trials
(Lefebvre 2011); we added some of the search strategy study de-
sign terms as used by the UK Cochrane Centre (Lefebvre 2011)
to the Embase Strategy.
We performed a further search in October 2014. We added three
studies to Characteristics of studies awaiting classification and we
will incorporate them into the review at the next update.
Searching other resources
To identify unpublished studies and those in progress, we searched
the following trials registers:
• ClinicalTrials.gov (www.clinicaltrials.gov);
• Current Controlled Trials (www.controlled-trials.com);
• Australia New Zealand Clinical Trials Registry (http://
www.anzctr.org.au/);
• Clinical Trial Results (www.clinicaltrialresults.org);
• WHO International Clinical Trials Registry Platform
(ICTRP) (www.who.int/ictrp/en).
We examined the reference lists of all eligible trials and relevant
systematic reviews to identify any further trials that may have been
missed by the electronic searches.
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Data collection and analysis
Assistance with running the search and collating results was pro-
vided by the Cochrane Injuries Group’s Trials Search Co-ordina-
tor.
Selection of studies
Two review authors (McNab and Dorofaeff ) screened the titles
and abstracts of all trials identified through the search for potential
inclusion on the basis of study design, intervention and partici-
pants. Following this, two authors examined in further detail the
full text of potentially eligible studies (McNab reviewed each, with
each additional author reviewing one to two studies) to determine
which trials met the full inclusion criteria. We resolved any uncer-
tainty or discrepancy through discussion.
Data extraction and management
Two authors independently performed data extraction for each
study and recorded this information on a data extraction form.
We resolved any difference of opinion by discussion. We contacted
the original study authors regarding missing data or data queries.
Assessment of risk of bias in included studies
We recorded the following information for all included studies:
• the method of randomisation sequence generation;
• the method of allocation concealment;
• whether the treatment allocation was blinded/not blinded
and to whom (participants, clinicians, outcome assessors);
• whether there was incomplete outcome data and whether
withdrawals and drop-outs were described;
• whether all participants were analysed using the intention-
to-treat principle.
We applied a judgement to each of these domains as to whether
there was a low, high or unclear risk of bias. This was based on
guidance in the Cochrane Handbook for Systematic Reviews of In-
terventions (Higgins 2011).
Measures of treatment effect
We presented dichotomous outcomes as summary risk ratios with
95% confidence intervals. Whenever there were no events for one
treatment group, we added 0.5 to each cell to allow the calculation
of effect estimates, as recommended in the Cochrane Handbook
for Systematic Reviews of Interventions. For continuous outcomes,
we calculated mean differences for individual studies and also for
the pooled estimates. We presented these with 95% confidence
intervals.
Unit of analysis issues
In many circumstances, repeated observations were performed on
each participant (e.g. serum sodium could be tested at multiple
time points). In addition, differently designed studies measured
observations at different time points to each other: for example,
one study measured serum electrolytes after 12 hours of fluid ther-
apy (Saba 2011), while another measured after six hours and then
24 hours of fluid therapy (Montañana 2008).
The primary outcome for the systematic review was hyponatraemia
at any time point while maintenance intravenous fluids were be-
ing administered. This allows for repeated observations. Where
hyponatraemia was noted in the same participant on multiple oc-
casions, we analysed the observation only once. In some studies it
was unclear whether the same patient was hyponatraemic at multi-
ple time points or whether a new participant had become hypona-
traemic. In this situation, we contacted the authors to ascertain
this information. If additional information was not available, we
only included the outcome data collected at the first time point in
the primary analysis.
For continuous outcomes (e.g. mean serum sodium), there may be
multiple observations for the same outcome, or the same outcome
may be recorded at different time points in different studies, or
both. To account for this, we studied arbitrary time ’blocks’. The
time blocks for continuous outcomes were:
• 6 to 12 hours; and
• > 12 to 24 hours.
Where fluid composition was investigated as part of a larger fac-
torial trial, we combined the summary estimates of the main ef-
fect for fluid type whenever there was no interaction between the
fluid type and the other intervention being investigated. For three-
armed trials, we combined arms with the same fluid composition,
regardless of the fluid rate being administered. We performed a
sensitivity analysis, including only arms where the administered
rate was balanced.
Dealing with missing data
Where dataweremissing for trials whichmet the inclusion criteria,
we contacted the trial authors. Where data had not been collected
for a study or were not available, we only analysed the available
data. We did not impute missing data for drop-outs.
Assessment of heterogeneity
We performed a meta-analysis of all trials meeting the inclusion
criteria using a fixed-effect model.We used the I2 statistic to detect
significant levels of heterogeneity.
Assessment of reporting biases
We searched trial registries and contacted the investigators of un-
published, registered trials.
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Data synthesis
We used ReviewManager software to carry out the statistical anal-
ysis (RevMan 2011). We used a fixed-effect model of meta-anal-
ysis to estimate the combination of intervention effects across the
studies.
Subgroup analysis and investigation of heterogeneity
We performed subgroup analyses on the primary outcome to in-
vestigate the effects of the following:
• The sodium concentration of the hypotonic fluid. The
sodium concentration can differ markedly in fluids considered to
be hypotonic. We performed a subgroup analysis, grouping the
hypotonic fluids according to sodium concentration:
◦ < 70 mmol/L sodium;
◦ ≥ 70 mmol/L and < 125 mmol/L sodium.
• Surgical patients versus medical patients.
• Fluid rate:
◦ maintenance rate (80% to 120% of standard
maintenance rate as defined by Holliday 1957;
◦ restricted rate ≤ 70% of standard maintenance rate.
• Age:
◦ less than one year old;
◦ one to five years old;
◦ five to 18 years old.
• Severity of illness:
◦ intensive/critical care unit patients;
◦ non-intensive/critical care unit patients.
Sensitivity analysis
We performed a sensitivity analysis excluding studies where the
intervention and control groups were not balanced for all factors
other than fluid composition. We performed a further sensitivity
analysis excluding studies that randomised patients who were hy-
ponatraemic at baseline. We planned neither of these sensitivity
analyses a priori.
R E S U L T S
Description of studies
Results of the search
The initial search of titles and abstracts revealed 14 potentially
eligible studies, for which we obtained the full text (Figure 1).
One study, written in Turkish, required full translation (Da li
1997); after this was obtained it became clear that the study pre-
dominantly examined intraoperative fluid replacement rather than
maintenance hydration. We therefore excluded this study (see
Excluded studies).
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Figure 1. Study flow diagram.
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Wealso excluded a further study examining intravenous fluid com-
position in gastroenteritis after it was established that the fluid was
given predominantly to replace a pre-existing deficit at rates that
far exceeded standard maintenance hydration (Neville 2006).
One title also not included was published only in protocol form
(Flaring 2011). This three-armed design aimed to compare 40,
70 and 140 mmol/L of sodium in 51 children with complicated
appendicitis. Contact with the author revealed that the study had
been prematurely ceased due to low recruitment, with outcome
data on only one participant.
One study was available only in abstract form (conference pre-
sentation Ang 2010). This study of 19 children admitted to an
Emergency Department in the Philippines compared 140 mmol/
L of sodium with 40 mmol/L of sodium. Without the full details
of the study available, insufficient information was available for
inclusion in the meta-analysis. A further study was also published
in abstract form (conference presentation Cuello 2012). However,
contact with the author provided additional information to allow
inclusion in this review.
We searched databases of registered protocols for potentially eligi-
ble studies in progress. This revealed a further five studies. Three
studies (McNab 2014; Baron 2013; Pemde 2014) have since been
published and will be incorporated into the review at the next up-
date. Additional information is not available regarding the remain-
ing two studies (CTRI/2010/091/000398; NCT00632775).
Following the search process, we deemed 10 studies eligible for
inclusion.
We have added three study reports from an updated search in Oc-
tober 2014 to Studies awaiting classification and will incorporate
these in the next update.
Included studies
Ten studies were eligible for inclusion (Characteristics of included
studies; Table 2). We made contact with all authors to collect
additional information. All authors assisted with this request.
Trial design characteristics
Composition and rate of intravenous fluid administered
There were significant clinical differences between studies regard-
ing the composition of intravenous fluid administered (Table 2).
As stipulated in our inclusion criteria, all used an isotonic fluid as
a comparator, although this varied between Hartmann’s solution
(Brazel 1996), Hartmann’s solution with 5% dextrose (Coulthard
2012), 0.9% sodium chloride (Yung 2009), and 0.9% sodium
chloride with 5% dextrose (Choong 2011; Cuello 2012; Kannan
2010; Saba 2011). One study used both 0.9% sodium chloride
with 2.5% dextrose and 0.9% sodium chloride with 5% dextrose
(Neville 2010). Two studies,Montañana 2008 andRey 2011, used
unnamed solutions containing 140 mEq/L of sodium and 136
mmol/L of sodium, respectively.
There was further, and arguably more significant, heterogeneity
regarding the hypotonic intervention fluid used by each study.
Yung 2009 used 0.18% sodium chloride with 4% dextrose, while
Kannan 2010 added slightly more dextrose (0.18% sodium chlo-
ride with 5% dextrose). Cuello 2012 used a similar fluid (0.2%
sodium chloride with 5% dextrose). Brazel 1996 used both 0.3%
sodium chloride with 3% dextrose and 0.18% sodium chloride
with 4% dextrose for its hypotonic intervention fluid. Three stud-
ies used 0.45% sodium chloride with 5% dextrose (Choong 2011;
Coulthard 2012; Saba 2011). Neville 2010 again used two fluids
with differing dextrose concentrations (0.45% sodium chloride
with 2.5% dextrose and 0.45% sodium chloride with 5% dex-
trose). Montañana 2008 and Rey 2011 again used unnamed solu-
tions. Montañana’s composition differed depending on the partic-
ipant’s weight, but contained a sodium concentration of between
20 and 100 mEq/L corresponding to 2 to 4 mEq/kg/24 hours.
Rey’s hypotonic fluid contained a sodium between 30 mmol/L
and 50 mmol/L.
The rates at which fluid was administered differed between stud-
ies (Table 2). Choong 2011 and Saba 2011 both left the rate to
the treating physician’s discretion, while Cuello 2012, Montañana
2008 and Rey 2011 stipulated that the rate should be prescribed
according to Holliday and Segar’s formula (Holliday 1957). The
patients in the Brazel 1996 study all received fluid at 1.5 ml/kg/
hour. Neville 2010 and Yung 2009 both conducted four-armed
studies: Neville randomised the isotonic and hypotonic groups to
100% or 50% maintenance rates, while Yung randomised them
to full or 2/3 maintenance rates. The three-armed study, Kannan
2010, gave isotonic fluid at full maintenance rates and hypotonic
fluid at either maintenance or 2/3 maintenance rates. In the study
conducted by Coulthard 2012, patients in the isotonic arm re-
ceived full maintenance rates, while those in the hypotonic arm
received 2/3 maintenance rates.
Duration of fluid therapy and timing of outcome
measurements
The duration of fluid therapy and timing of outcome measure-
ments differed between studies (Table 3). As previously discussed,
our primary outcome was hyponatraemia at any time point, which
allowed for clinical heterogeneity in this area.
Baseline characteristics of participants
Setting
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All studies were performed in tertiary paediatric hospitals, with
the exception of Kannan 2010, which was performed in a general
(adult and paediatric) university hospital andRey 2011, whichwas
conducted across three university hospitals. Four studies were con-
ducted in Australia (Brazel 1996; Coulthard 2012; Neville 2010;
Yung 2009), two studies occurred in both Spain (Montañana
2008; Rey 2011) and Canada (Choong 2011; Saba 2011), while
the remaining studies took place in India (Kannan 2010) and
Mexico (Cuello 2012).
Inclusion and exclusion criteria
The inclusion and exclusion criteria for the included studies are
outlined in Table 4.
Four studies were performed only in surgical populations.
Of these, Choong 2011 recruited patients undergoing elective
surgery, while Neville 2010 recruited patients requiring either
elective or emergency surgery. Patients in Coulthard 2012 were
those admitted to the paediatric intensive care unit (PICU) fol-
lowing spinal instrumentation or craniotomies, while Brazel 1996
included only those who underwent primary corrective surgery
for adolescent idiopathic scoliosis. Four studies were performed
exclusively in PICU populations (Coulthard 2012; Montañana
2008; Rey 2011; Yung 2009). Cuello 2012 included two patient
groups: those admitted with gastroenteritis or those undergoing
non-urgent surgery. Kannan 2010 and Saba 2011 did not restrict
recruitment on the basis of surgery or PICU requirements.
The exclusion criteria varied between studies; in general, patients
were excluded if isotonic or hypotonic fluids were considered to be
contraindicated. This was usually where an underlying diagnosis
or medication affected water and electrolyte homeostasis. Cuello
2012 also excluded patients with chronic illnesses.
Studied outcomes
The primary outcomes for all included studies are listed in Table
2. There was significant variation between studies regarding the
chosen primary outcome.
Three studies elected to use hyponatraemia as their primary out-
come (Choong 2011; Kannan 2010; Montañana 2008), although
the definitions of hyponatraemia differed (< 135 mEq/L for the
former two and < 130 mEq/L for Kannan’s study).
Three studies reported change in plasma sodium as their primary
outcome (Neville 2010; Rey 2011; Yung 2009). Two of these
elected the time frame for change to be from admission to 12 to 24
hours later, while one examined change in sodium from induction
of anaesthesia to eight hours postoperatively.
The remaining studies had unique primary outcomes; Brazel 1996
reported the development of syndrome of inappropriate antidi-
uretic hormone secretion (SIADH), defining this on the basis of
serum sodium, serum osmolarity and urine osmolarity; Saba 2011
reported rate of change of sodium; and Coulthard 2012 reported
mean plasma sodium 16 to 18 hours postoperatively, while Cuello
2012 described mean plasma sodium after four and eight hours
of treatment, as well as the percentage of patients who developed
hyponatraemia.
All 10 studies could provide data for the primary outcome for this
systematic review (hyponatraemia of < 135 mmol/L at any time
point during the study).
Excluded studies
See Characteristics of excluded studies.
We examined the full text of two studies in detail prior to exclusion.
Neville 2006 performed a study comparing 0.9% sodium chloride
+ 2.5% dextrose with 0.45% sodium chloride + 2.5% dextrose in
children with a presumed diagnosis of gastroenteritis. The rate of
fluid replacementwas determined by the treating clinician and fol-
lowed one of two clinical protocols: 10 ml/kg/hour for four hours
or maintenance rate plus estimated dehydration replaced over 24
hours. Of note, 76% of patients were administered fluid using the
former protocol, which is at least 250% of standard maintenance
rates. As such, the patients were not given intravenous fluid for the
primary purpose of maintenance hydration but, rather, to replace
a pre-existing deficit.
The study byDa li 1997 was similarly examined in detail, includ-
ing obtaining a Turkish translation. Children undergoing surgery
were randomised to receive one of three different fluid composi-
tions intraoperatively: Ringer’s lactate, Ringer’s lactate + 1% dex-
trose or 0.3% sodium chloride + 3.3% dextrose. However, the rate
administered once again indicated that fluids were given for pur-
poses other than maintenance hydration. Based on the patient’s
age, fluids were given at either 25 ml/kg/hour or 15 ml/kg/hour
for the first hour, followed by 6 ml/kg/hour. Almost all the treat-
ment periods were less than an hour, meaning the rates received
were well in excess of accepted maintenance.
One excluded study was published only in protocol form (Flaring
2011). This three-armed design aimed to compare 40, 70 and 140
mmol/L of sodium in 51 children with complicated appendicitis.
Contact with the author revealed that the study had been prema-
turely ceased due to low recruitment, with outcome data on only
one participant.
A conference presentation (Ang 2010) was published only in ab-
stract form and was also excluded. This study of 19 children ad-
mitted to an Emergency Department in the Philippines compared
140 mmol/L of sodium with 40 mmol/L of sodium. Without
the full details of the study available, insufficient information was
available for inclusion in the review.
Risk of bias in included studies
Allocation
Brazel 1996, the first quasi-randomised controlled trial to compare
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hypotonic and isotonic fluid, had a potential selection bias as there
was no random sequence generation or allocation concealment.
Consecutive patients were given alternating solutions. The rest of
the studies all had a low risk of selection bias.
Blinding
Choong 2011, Saba 2011 and Yung 2009 conducted studies with
the participants, treating team and research team all blinded to
the fluid type. Choong also blinded the treating team to the pri-
mary outcome measure. While the other studies did not blind
their intervention fluids to the treating team, this still presents a
relatively low risk of bias. Our primary outcome measure is ob-
jective (serum sodium) and all studies stipulated times for bloods
to be taken. However, if additional blood tests were taken at non-
specified time points, these results were also included in our meta-
analysis, which could introduce a performance bias. That is, if a
clinician is concerned because a patient is receiving a certain com-
position of fluid, they may request additional testing, increasing
the likelihood of reaching our primary outcome.
Incomplete outcome data
With the exception of Saba’s small study (Saba 2011), which had
a moderate number of drop-outs, there was reasonable retention
of patients (between 83% and 100%). Saba’s study enrolled 25
patients in each intervention arm. However, only 16 (64%) and
21 (84%) patients in each arm completed the study.
Selective reporting
While not all studies had registered protocols, all eligible studies
were able to provide data for the primary outcome of the meta-
analysis, making reporting bias unlikely.
Other potential sources of bias
A systematic biasmay have been introduced in themeasurement of
the serum sodium levels. While Choong 2011 described an addi-
tional intravenous line being placed in the majority of her patients
specifically for blood sampling andKannan 2010, Coulthard 2012
and Cuello 2012 also placed a separate line for blood sampling
(personal communication), the remaining studies did not describe
how the blood samples were obtained. If the samples were removed
from the same intravenous line into which study fluid was being
administered, there is potential for contamination. Even a small
volume of contamination from a hypotonic fluid could result in a
false positive primary outcome result. This could markedly influ-
ence the results of the meta-analysis.
Effects of interventions
See: Summary of findings for the main comparison
Hyponatraemia
The primary outcome for the systematic review was hypona-
traemia (< 135 mmol/L) occurring at any time point during the
study. This information was available for all eligible studies and is
presented in Analysis 1.1. When examining the data from eligible
studies, isotonic fluid appears to halve the risk of hyponatraemia
(risk ratio (RR) 0.48; 95% confidence interval (CI) 0.38 to 0.60).
We only used limited data for Montañana 2008. This study pre-
sented the incidence of hyponatraemia at specific time points (six
hours and 24 hours after commencing fluid). However, given that
the same patient could be counted on more than one occasion, the
overall rate of hyponatraemia during the studywas indeterminable.
Given this, we only included data obtained up until the first time
point (T6) in our primary analysis to avoid possible duplication.
We chose the first time point as, by the second time point, there
was relatively large attrition and patients could potentially have
been withdrawn unequally due to earlier hyponatraemia.
Cuello 2012 provided hyponatraemic data only for patients who
were normonatraemic at baseline; patients who remained hypona-
traemic were not included in this analysis.
All data were available and used for the remaining studies. There
was little statistical heterogeneity between the groups: I2 = 0%.
A total of 449 patients received isotonic fluid, while 521 received
hypotonic fluid, with 76 and 176 primary outcome events occur-
ring in each group respectively.
Hypernatraemia
Whether isotonic fluid increases the risk of hypernatraemia (> 145
mmol/L) remains unclear (see Analysis 1.2), with hypernatraemia
being an uncommon event in the meta-analysis.
Data from nine studies were available for inclusion with
Montañana’s data again only included until the patient had re-
ceived six hours of intravenous fluid. In total, 16 of the 437 pa-
tients receiving isotonic fluid and 17 of the 500 patients receiving
hypotonic fluid developed hypernatraemia. A broad confidence
interval of 0.65 to 2.38 makes it difficult to determine whether
there is an increased risk of hypernatraemia with isotonic fluid.
The confidence intervals of three individual studies were excep-
tionally large (Neville 2010; Rey 2011; Saba 2011), while risk ra-
tios were not calculable for a further three studies as they had no
episodes of hypernatraemia (Brazel 1996; Coulthard 2012; Cuello
2012).
The large study performed by Choong 2011 in a post-surgical
population, as well as the three-armed study by Kannan 2010,
suggest that there is unlikely to be a clinically significant difference
in rates of hypernatraemia between groups, however further large
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studies, currently underway (Table 2), will provide more informa-
tion regarding this.
Mean serum sodium
Mean serum sodium was examined following six to 12 hours and >
12 to 24 hours of intravenous fluid therapy (Analysis 1.3; Analysis
1.4).No study examined serum sodiumonmore thanone occasion
within these time blocks. The mean serum sodium was lower in
the hypotonic group at both time points.
Seven studies had data included in the six to 12-hour analysis;
for one study (Montañana 2008), the blood samples were taken
six hours after starting intravenous fluid, Neville 2010 and Cuello
2012 collected samples at after eight hours, and four studies had
blood samples collected 12 hours after starting intravenous fluid
(Choong 2011; Kannan 2010; Rey 2011; Saba 2011). The mean
serum sodiumwas lower for those receiving hypotonic fluid, with a
mean difference between treatment groups of 1.99 mmol/L (95%
CI 1.55 to 2.42). Only one study reported a low overall mean
serum sodium for patients receiving hypotonic fluid (Rey 2011:
133.7 mmol/L). No study reported an overall mean serum sodium
in the hypernatraemic range for children receiving hypotonic or
isotonic fluid.
Six studies had data available for inclusion in the > 12 to 24-
hour analysis (Choong 2011; Coulthard 2012; Kannan 2010;
Montañana 2008;Neville 2010; Rey 2011). ForCoulthard’s study,
the bloodswere collected between16 and18hours after commenc-
ing intravenous fluid, while Choong’s were collected the morning
of postoperative day two. The remaining studies collected sam-
ples after 24 hours of treatment. The mean difference between
treatment groups was less than the earlier time point, being 1.33
mmol/L (95% CI 0.81 to 1.85). Once again, after 24 hours of
intravenous fluid, the overall mean serum sodium was only in the
low range (134.2 mmol/L) for those receiving hypotonic fluids in
Rey 2011.
Adverse events
We examined death, seizures, cerebral oedema and overhydration
as adverse events (Analysis 1.5; Analysis 1.6; Analysis 1.7; Analysis
1.8). Out of 996 participants there was one death, one seizure
and there were no episodes of cerebral oedema, making these very
rare events within the studies. The post-surgical study by Choong
2011 was the only study to record any episodes of overhydration.
We did not find a statistically significant difference for any adverse
event. However, particularly for seizures (RR 0.62; 95% CI 0.03
to 15.02) and death (RR 5.59; 95% CI 0.23 to 135.17), broad
confidence intervals indicate that, despite the meta-analysis, the
power was insufficient to detect potential differences. We found
no difference in clinical episodes of overhydration (RR 1.14; 95%
CI 0.46 to 2.87). As no episodes of cerebral oedema were reported
in any study, risk ratios were incalculable for this rare outcome.
It is notable that most studies had safety restrictions built into
their methodology to ensure that high-risk patients were either
excluded or withdrawn from the study prior to serious adverse
events occurring.
Antidiuretic hormone, urine osmolality and urine
electrolytes
Choong 2011, Kannan 2010 and Neville 2010 all reported serum
antidiuretic hormone (ADH) levels. The data were not normally
distributed, so we did not carry out meta-analysis. However, in
each study there was no statistically significant difference between
the hypotonic and isotonic groups. ADH was frequently elevated
to a level above that normally associated with maximal antidiuresis
(3 to 5 pg/ml). This may explain why some patients are unable
to excrete effectively free water and develop hyponatraemia in the
presence of free water administration.
Three studies performed urine osmolality testing after 24 hours of
intravenous fluid, with no difference in urine osmolality between
the treatment groups (Coulthard 2012; Kannan 2010; Neville
2010) (Analysis 1.9). Four additional studies also provided in-
formation on urine osmolality: Cuello 2012 performed urine os-
molality after eight hours of treatment and found no significant
difference between treatment groups; Brazel 1996 presented data
only in a box plot format, but again found no significant differ-
ence; Yung 2009 provided only change in osmolality data and
Montañana 2008 presented non-normally distributed data after
six hours of intravenous fluid.
There were unsurprising differences in the urinary sodium con-
centration between treatment groups after 24 hours of treatment
(Analysis 1.10) (Choong 2011; Coulthard 2012; Kannan 2010;
Neville 2010). Again, further studies provided data that were not
included in the meta-analysis: Cuello 2012 provided data after
eight hours of intravenous fluid and found no significant differ-
ence between treatment groups; Yung 2009 described change in
urinary sodium, while Montañana 2008 again presented data at
six hours of treatment, whichwere not normally distributed.Urine
biochemistry is difficult to interpret in the context of a meta-anal-
ysis, as it is more relevant for individual patients and dependent
on the hydration status, serum biochemistry and fluid received. It
would be interesting, although not possible within the meta-anal-
ysis, to evaluate the urine biochemistry for specific hyponatraemic
patients.
Subgroup analyses
Sodium concentration of hypotonic fluid
The range of sodium concentrations in hypotonic fluids is broad
(e.g. some studiesmay use a hypotonic fluid containing30mmol/L
of sodium, while another may use a hypotonic fluid containing 77
mmol/L of sodium). It could be reasoned that, if hypotonic fluid
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increases the risk of hyponatraemia, a more profoundly hypotonic
fluid would exacerbate this. We performed a subgroup analysis,
grouping the hypotonic fluids according to sodium concentration:
• sodium ≥ 70 mmol/L and ≤ 125 mmol/L (moderately
hypotonic fluid);
• sodium < 70 mmol/L (very hypotonic fluid).
Four studies used a moderately hypotonic fluid (Choong 2011;
Coulthard 2012; Neville 2010; Saba 2011), while five used a very
hypotonic fluid (Brazel 1996; Cuello 2012; Kannan 2010; Rey
2011; Yung 2009). The composition of hypotonic fluid used in
Montañana 2008 differed according to weight and was not in-
cluded in this analysis.
Somewhat surprisingly, this subgroup analysis suggests that, when
compared with isotonic fluid, there is a similar risk of hypona-
traemia whether using a profoundly ormoderately hypotonic fluid
(Analysis 1.11).
Surgical patients versus medical patients
We performed a subgroup analysis to explore whether being a
surgical or medical patient influences the risk of developing hy-
ponatraemia (Analysis 1.12). Four studies with data available for
our primary outcome were performed exclusively in postoperative
patients (Brazel 1996; Choong 2011; Coulthard 2012; Neville
2010), while Kannan 2010 examined medical patients. Cuello
2012, Rey 2011 and Saba 2011 performed studies examining both
medical and surgical patients; data on each subgroup could be
analysed. The remaining studies did not provide the case mix data
to allow analysis according to surgical and medical subgroups.
In the 529 surgical patients with available data, the meta-analy-
sis shows that isotonic fluid is protective against hyponatraemia
when compared with hypotonic fluid (RR 0.48; 95% CI 0.36 to
0.66). When examining the medical cohort, Saba 2011 reported
no cases of hyponatraemia in the six patients each receiving iso-
tonic andhypotonic fluid. A protective differencewas shown in the
gastroenteritis population in Cuello 2012, the medical intensive
care population in Rey 2011 and the general medical population
in Kannan 2010, when using isotonic compared with hypotonic
fluid (RR 0.29; 95% CI 0.16 to 0.55).
Fluid rate
We compared the results of those randomised to receive fluid at
maintenance rates (as per Holliday 1957) with the results of those
randomised to receive fluid at≤ 70%maintenance (Analysis 1.13).
Studies where rates were prescribed at the treating physician’s dis-
cretion were not included in this analysis. Five studies had data
available for the maintenance rate analysis (Cuello 2012; Kannan
2010; Montañana 2008; Neville 2010; Rey 2011). They showed
strong evidence of a decreased risk of hyponatraemia when iso-
tonic fluid compared with hypotonic fluid was used at mainte-
nance rates (RR 0.45; 95% CI 0.33 to 0.61). When rates were re-
stricted to≤ 70% maintenance, only one study had data available
for analysis (Neville 2010). There was a similar risk ratio for hy-
ponatraemia to the overall comparison (RR 0.45; 95% CI 0.18 to
1.16). This suggests that fluid restriction does not protect against
hyponatraemia, although this cannot be concluded with certainty,
likely due to insufficient power.
Three further studies examined the issue of fluid restriction, but
were not included in the meta-analysis. Yung 2009 conducted a
four-armed factorial study comparing 0.9% sodium chloride with
0.18% sodium chloride + 4% dextrose at full and 2/3 of mainte-
nance rates. These data were not included in the subgroup analysis
as data on episodes of hyponatraemia were not available for these
subgroups. Kannan 2010 conducted a three-armed study compar-
ing isotonic fluid at full maintenance rates with hypotonic fluid
at full maintenance and 2/3 of maintenance rates. While the full
maintenance data could be analysed as there was both an isotonic
and hypotonic arm, only hypotonic fluid was given at a restricted
rate, and therefore could not be analysed. Similarly, Coulthard
2012 gave isotonic fluid at a maintenance rate and hypotonic fluid
at a restricted rate. Without isotonic and hypotonic arms for both
subgroups, we could draw no conclusions regarding the impact of
rate.
Age
Seven studies were able to provide information on rates of hy-
ponatraemia according to age (Choong 2011; Coulthard 2012;
Cuello 2012; Kannan 2010; Neville 2010; Rey 2011; Saba 2011).
There appears to be a similar association between fluid type and
hyponatraemia in each age stratum (Analysis 1.14).
Severity of illness
Isotonic fluid decreases the risk of hyponatraemia when compared
with hypotonic fluid in both intensive care (RR 0.48; 95% CI
0.37 to 0.64) and non-intensive care patients (RR 0.45; 95% CI
0.29 to 0.68) (Analysis 1.15).
Sensitivity analyses
Unbalanced interventions
Two studies included in the primary analysis had data which could
be considered unbalanced as the isotonic and hypotonic arms were
randomised to receive different volumes of fluid. Kannan 2010
performed a three-armed study comparing isotonic fluid at main-
tenance rates with hypotonic fluid at maintenance rates as well
as hypotonic fluid at restricted rates. For the primary meta-anal-
ysis, we amalgamated the data from the hypotonic arms together.
However, a potential bias could be introduced by this approach as
the isotonic and hypotonic groups are no longer equivalent for all
factors other than fluid composition. Similarly, Coulthard 2012
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compared isotonic fluid at maintenance rates with hypotonic fluid
at restricted rates. Again, these groups are not balanced, poten-
tially introducing a bias. For the sensitivity analysis, we removed
Coulthard’s data and only included the maintenance rate arms of
Kannan’s study (Analysis 1.16).
The findings of the sensitivity analysis are almost identical to that
of the primary analysis; using an isotonic fluid for maintenance
hydration appears to be protective against the development of
hyponatraemia (RR 0.45; 95% CI 0.35 to 0.58).
Hyponatraemia at baseline
Some studies included in the primary analysis recruited patients
with abnormal serum sodium levels (< 135mmol/L) at enrolment.
Saba 2011 excluded patients only if their serum sodium was < 133
mmol/L, while Kannan 2010, Montañana 2008 and Rey 2011
excluded patients with lower serum sodiums (< 130 mmol/L).
Neither Neville 2010 nor Coulthard 2012 restricted enrolment
on the basis of initial sodium. The primary outcome for the meta-
analysis was hyponatraemia (an undesirable outcome) at any time
point after commencing intravenous fluid; however, it is likely
that some patients in these studies were recorded as having met
the primary outcome despite a clinical improvement in serum
sodium. That is, an initially hyponatraemic patient whose sodium
improved towards the normal range could be judged as havingmet
the primary outcome for the meta-analysis.
To account for this, we undertook a sensitivity analysis, exclud-
ing studies where any patients were hyponatraemic at baseline
(Analysis 1.17). Of note, we included data from Cuello 2012 in
this analysis; while this study recruited patients with sodium as low
as 125 mmol/L, only those who were normonatraemic at baseline
were included in its hyponatraemia analysis.
Again, this sensitivity analysis did not substantially alter the finding
that isotonic fluid appears to be protective against hyponatraemia
when comparedwith hypotonic fluid,when given formaintenance
hydration (RR 0.49; 95% CI 0.34 to 0.71).
D I S C U S S I O N
Summary of main results
In the populations studied, those who received isotonic fluid for
intravenous maintenance hydration, when compared with those
who received hypotonic fluid, had a substantially lower risk of
hyponatraemia.
The protective effect of isotonic fluid in reducing hyponatraemia
was maintained when we examined most subgroups.
Overall completeness and applicability of
evidence
Populations studied
Some gaps in the evidence remain; in particular, the majority of
studies were conducted in surgical and/or intensive care popula-
tions. There was a paucity of evidence for those receiving fluids
beyond 24 hours.
Timing of outcomes and follow-up period
Continuous outcomes were examined in time blocks of six to 12
hours and ≥ 12 to 24 hours. There were few meaningful 48-hour
data, as studies either did not examine this later time point or
most patients had ceased intravenous fluids by this time point. It
is, therefore, difficult to extrapolate our data for patients requir-
ing more than a day of intravenous fluid. The short follow-up
period for some of the studies did introduce a potentially signifi-
cant problem: if a patient became hyponatraemic for the first time
after the study ended, the true effect of the fluid type would not
have been captured. Similarly, most studies did not examine the
primary outcome prior to 12 hours of therapy. This may miss pa-
tients who rapidly became hyponatraemic, then had an improving
sodium level.
Quality of the evidence
Study limitations
In general, all the studies appeared to be conducted in a robust
and systematic manner. We excluded no studies due to concerns
with poor quality or potential bias. However, a potential factor
negatively affecting the quality of the primary outcome exists, as
only one study described the method of blood sampling (Choong
2011), with a further three studies providing unpublished infor-
mation (Coulthard 2012; Cuello 2012; Kannan 2010). If the re-
maining studies sampled blood from an intravenous line running
study fluid, false positive results arising from contamination could
have markedly influenced the results of this meta-analysis. How-
ever, those studies that described a separate intravenous line being
used for blood sampling found comparable treatment effects to
the overall meta-analysis, reducing the likelihood that this has had
a significant impact on the primary result.
Indirectness
No indirect outcomes were assessed.
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Heterogeneity
This meta-analysis was limited by the clinical heterogeneity of the
studies, which compromises the ability to compare studies fairly.
In particular, the difference in sodium concentrations of the hy-
potonic fluid studied was vast, reflecting the broad range of prac-
tice occurring internationally (Davies 2008; Freeman 2012; Way
2006). Despite this, the results were consistent between studies
and maintained in most of the subgroup analyses, implying that
the results may be generalised to a wide range of settings.
There was no apparent heterogeneity of results between studies or
subgroup analyses.
Imprecision of results
There was imprecision in a number of secondary outcomes due
to the low event numbers. This is reflected in the downgrading
of the GRADE domain (see Summary of findings for the main
comparison).
Publication bias
We searched databases of registered protocols to identify unpub-
lished studies and all authors of included studies replied to requests
for additional, unpublished data.
Potential biases in the review process
Primary outcome limitations
We selected hyponatraemia (< 135 mmol/L) as themost appropri-
ate, pragmatic and ethical primary outcome for the meta-analysis,
acknowledging that there are some limitations with this.
Sodium stability or a serum sodium level that slowlymoves towards
the normal range, rather than normonatraemia, may be a more
clinically appropriate outcome for a patient with a low serum
sodium at baseline. However, these data are dependent on the
baseline sodium level for an individual patient: these data are not
available in the context of a meta-analysis.
We chose mild to moderate hyponatraemia as the primary out-
come despite it being unlikely to be associated with any adverse
neurological consequences. We used it in this context as a surro-
gate marker for risk of more severe hyponatraemia, which has been
associated with cerebral oedema. While severe hyponatraemia (<
130 mmol/L) was an outcome for some of the included studies,
allowing at-risk patients to become severely hyponatraemic raises
significant safety concerns and it was, therefore, not considered
appropriate for use in this meta-analysis. In addition, some stud-
ies included safety measures that prevented the development of
severe hyponatraemia. If sodium decreased, the fluid prescription
was changed and the patient was removed from subsequent data
analysis. This made it unlikely for any patients to develop severe
hyponatraemia, but also limits the interpretation of data beyond
the first measurement of hyponatraemia.
Secondary outcome limitations
Mean serum sodium
When examining mean sodium as a secondary outcome, choos-
ing the ideal time point to study was difficult. It would seem
plausible that, if hypotonic fluids decrease mean serum sodium, a
protracted length of treatment would decrease the serum sodium
further. That is, the longer the treatment length, the lower the
serum sodium. However, it is also logical that, for the majority of
patients, the severity of their illness will improve with length of
treatment. This, in turn, should decrease the likelihood of nonos-
motic antidiuretic hormone (ADH) secretion with time, allowing
the body to excrete excess water and minimising any reduction
in serum sodium. It could, therefore, be expected that the nadir
in serum sodium will be affected by an interplay between severity
of illness and length of treatment. There is a lack of evidence to
suggest when the nadir would be expected in any given patient
population, and whether it was captured by our time brackets.
Regardless, in the two time brackets studied, mean serum sodium
was consistently lower in the treatment group receiving hypotonic
fluid.
Adverse events
Little can be said regarding serious adverse events as most studies
had safety restrictions built into their methodology to ensure ad-
verse events were avoided, or high-risk patients were withdrawn
from the study prior to the occurrence of serious adverse events,
or both. There is inadequate evidence to suggest isotonic fluids
increase the risk of hypernatraemia and overhydration, which have
been suggested as potential adverse outcomes (Coulthard 2008;
Hatherill 2004; Holliday 2004; Holliday 2005).
While it is unclear whether there is an increased risk of hyperna-
traemia when isotonic fluids are used, it is worth noting that the
total number of episodes of hypernatraemia in the meta-analysis
(33/937) was significantly lower than the number of episodes of
hyponatraemia (252/970). In addition, in studies where hyper-
natraemia was examined as an outcome, the data do not address
whether this is fromhypernatraemic dehydration or excess sodium
infusion. However, further large clinical trials, currently under-
way, examining hypernatraemia as an outcome of isotonic fluid
administration, may be beneficial.
Overhydration has been suggested as a possible consequence of the
prescription of isotonic fluids, as an increased sodium load could
potentially lead to interstitial fluid overload (Holliday 2005). This
situation could be particularly problematic in developing countries
where ’rescue’ medications or access to ventilatory support may
17Isotonic versus hypotonic solutions for maintenance intravenous fluid administration in children (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
not be available. Again, further large trials examining this outcome
may assist.
Agreements and disagreements with other
studies or reviews
The result of the primary meta-analysis is consistent with all ran-
domised controlled trials comparing isotonic with hypotonic fluid
for maintenance hydration in children. Each study conducted has
concluded that isotonic fluid is protective against hyponatraemia.
A U T H O R S ’ C O N C L U S I O N S
Implications for practice
Traditionally, maintenance intravenous fluid prescriptions have
been calculated on presumed nutritional sodium requirements,
which results in an intravenous fluid containing approximately 30
mmol/L to 50 mmol/L of sodium: this is markedly less sodium
than plasma. The data from this meta-analysis support reconsid-
eration of these guidelines.
This review shows that isotonic maintenance fluids with sodium
concentrations similar to that of plasma reduce the risk of hy-
ponatraemia. These results apply for the first 24 hours of admin-
istration, in a wide age group of primarily surgical paediatric pa-
tients with varying severities of illness. There was no evidence of
an increase in rates of hypernatraemia or adverse effects, although
given the rarity of adverse events associated with intravenous fluid
administration, future research may inform this further.
It is important to recognise that not all hypotonic fluids are the
same and not all isotonic fluids are the same. Readily available hy-
potonic intravenous fluids have sodium concentrations between
30 mmol/L and 77 mmol/L. However, no difference was seen in
the risk of hyponatraemia whether moderately or profoundly hy-
potonic fluid was administered. This suggests that using a moder-
ately hypotonic fluid for maintenance hydration may not be ade-
quate to mitigate the risk of hyponatraemia.
Similarly, not all isotonic fluids are the same. Readily available
isotonic fluids contain between 130 mmol/L and 156 mmol/L
of sodium. In addition to sodium, they also contain markedly
different chloride concentrations. Some also contain other con-
stituents, including glucose, calcium, potassium, magnesium and/
or bicarbonate precursors. When choosing an intravenous fluid, it
is important to consider the full composition of the intravenous
fluid based on an individual patient’s requirements. This has not
been covered by this review. Given that hyponatraemia can still
occur, despite isotonic fluid being administered, these studies also
support the individualisation of intravenous fluid prescription and
monitoring of patients for electrolyte changes, as well as potential
adverse effects.
Neonates were also excluded from this meta-analysis; the results
cannot be generalised to this group.
Implications for research
This area has been a growing area for researchers, particularly over
the past decade. Our primary meta-analysis included 970 partic-
ipants. Currently, there are a further five registered protocols for
studies at various stages of completion, totalling a further 966 par-
ticipants. The data from these studies will contribute substantially
to the available evidence. In particular, they will examine a broader
range of diagnoses and contribute to our understanding of poten-
tial adverse events.
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C H A R A C T E R I S T I C S O F S T U D I E S
Characteristics of included studies [ordered by study ID]
Brazel 1996
Methods Randomised controlled trial
Participants 12 female, adolescent patients undergoing primary corrective surgery for idiopathic
scoliosis
Interventions Isotonic (Hartmann’s)
Hypotonic (either 0.3% saline + 3% dextrose or 0.18% saline + 4% dextrose)
Rate: 1.5 ml/kg/hr
Outcomes Development of SIADH
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
High risk Alternated solutions for sequential patients
Allocation concealment (selection bias) High risk No allocation concealment as alternated solutions for se-
quential patients
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk No blinding, but outcomes (blood tests) were objective
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk No blinding, but blood test results were objective
Incomplete outcome data (attrition bias)
All outcomes
Low risk -
Selective reporting (reporting bias) Unclear risk No registered protocol
Other bias Unclear risk Method of blood sampling not described. If blood was
taken from the same IV line into which the study fluid
was administered, potential contamination could have
occurred, artefactually affecting the laboratory sodium
result
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Choong 2011
Methods Randomised controlled trial
Participants 258 elective surgical patients aged 6 months to 16 years
Interventions 0.9% saline + 5% dextrose
0.45% saline + 5% dextrose
Rate determined by treating physician
Outcomes Hyponatraemia < 135 mmol/L
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated randomisation sequence prepared
by a statistician (in a 1:1 ratio), using block sizes of 6 and
stratified according to postoperative admission ward
Allocation concealment (selection bias) Low risk Randomisation codemaintained by the research pharma-
cist and concealed from all research personnel. Masked
study solutions were numbered consecutively and stored
in individual, correspondingly numbered containers. Re-
search assistants enrolled participants and assigned the
intervention from the sequentially numbered study con-
tainers
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Participants, medical and research staff members, inves-
tigators and data safety monitoring committee members
were blinded. Solutions were repackaged individually in
identical, sealed, opaque bags, identified only with the
study number, additives (e.g. potassium chloride concen-
tration) and the patient’s name
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk All caregivers were blinded to study-specific investigation
results
Incomplete outcome data (attrition bias)
All outcomes
Low risk 83% primary outcome data in isotonic group, 86% in
hypotonic group (lack of attrition well described)
Selective reporting (reporting bias) Low risk Registered protocol
Other bias Unclear risk -
22Isotonic versus hypotonic solutions for maintenance intravenous fluid administration in children (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Coulthard 2012
Methods Randomised controlled trial
Participants 82 children undergoing spinal instrumentation, craniotomy for brain tumour resection
or cranial vault remodelling
Interventions Hartmann’s + 5% dextrose at full maintenance rate
0.45% saline + 5% dextrose at 2/3 maintenance rate
Outcomes Mean plasma sodium 16 to 18 hrs postoperatively
Notes Different fluid compositions were given at different rates
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Computer-generated random numbers in blocks of 10,
stratified by type of surgery (spinal or cranial)
Allocation concealment (selection bias) Low risk Consecutively numbered, opaque envelopes
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Not blinded. Low risk of bias as strict pathways existed
to alter management
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Not blinded. Risk of bias low as clinical care pathway
followed
Incomplete outcome data (attrition bias)
All outcomes
Low risk No patient withdrew after recruitment, 3 lost to follow-
up because of early discharge to ward, from both groups
Selective reporting (reporting bias) Low risk Registered protocol
Other bias Unclear risk -
Cuello 2012
Methods Randomised controlled trial
Participants 72 participants aged 16 months to 14 years with either of 2 conditions: a) gastroenteritis
with moderate dehydration and unable to tolerate fluids; b) children requiring non-
urgent surgery and requiring maintenance intravenous hydration during their admission
Interventions 0.9% saline + 5% dextrose +/- 20 mmol/L KCl at maintenance rate
0.2% saline + 5% dextrose +/- 20 mmol/L KCl at maintenance rate
Outcomes Main outcome was plasma sodium at 4 (T4) and 8 (T8) hours, and the percentage of
patients who developed hyponatraemia (> 125 mEq/L and < 135 mEq/L)
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Cuello 2012 (Continued)
Notes Abstract only published to date
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Usedpermuted blocks of 10participants. A list was gener-
ated using Internet-based software (randomization.com)
Allocation concealment (selection bias) Low risk The list was concealed by the main investigator (CC);
text messages were sent to the investigator/clinician in
turn when a patient agreed to participate in the study
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Participants, but not personnel, were blinded. Outcomes
(blood tests) were objective and performed at predeter-
mined time points
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk No blinding, but blood test results were objective
Incomplete outcome data (attrition bias)
All outcomes
Low risk No patient withdrawals
Selective reporting (reporting bias) Unclear risk Protocol not registered, but outcomes studied were sim-
ilar to other studies
Other bias Unclear risk Abstract only published to date. Full text yet to be peer
reviewed
Kannan 2010
Methods Randomised controlled trial
Participants Broad paediatric population aged 3 months to 12 years (university hospital in India);
167 participants
Interventions 0.9% saline + 5% dextrose at standard maintenance rate
0.18% saline + 5% dextrose at standard maintenance rate
0.18% saline + 5% dextrose at 2/3 restricted rate
Outcomes Hyponatraemia < 130 mEq/L
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
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Kannan 2010 (Continued)
Random sequence generation (selection
bias)
Low risk Separate randomisation sequence for each stratum using
Stata version 7.0
Allocation concealment (selection bias) Low risk Randomisation list and numbered envelopes prepared
offsite by independent staff. Sealed, opaque envelopes
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk No blinding, but outcome measures objective
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk No blinding, but outcome measures objective
Incomplete outcome data (attrition bias)
All outcomes
Unclear risk Not stated
Selective reporting (reporting bias) Low risk Registered protocol
Other bias Unclear risk -
Montañana 2008
Methods Randomised controlled trial
Participants 122 paediatric intensive care unit patients
Interventions Isotonic fluid (sodium 140 mEq/L)
Hypotonic fluid (sodium between 20 and 100 mEq/L corresponding to 2 to 4 mEq/kg/
24 hr)
Exact composition of fluids not stated
Rate: standard maintenance
Outcomes Hyponatraemia < 135 mEq/L
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Binary series with randomised numbers, using randomi-
sation function of the MS-Excel XP program of Win-
dows. Balanced block sampling with 2 block sizes: 4 and
6
Allocation concealment (selection bias) Unclear risk First author aware of sequence. Following admission, he
was contacted and provided the group allocation
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Montañana 2008 (Continued)
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Not blinded, but primary outcome objective
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Not blinded, but primary outcome objective
Incomplete outcome data (attrition bias)
All outcomes
Low risk 84% analysed - most drop-outs due to finishing fluid
prior to 6 hours
Selective reporting (reporting bias) Unclear risk Protocol not registered
Other bias Unclear risk Method of blood sampling not described. If blood was
taken from the same IV line into which the study fluid
was administered, potential contamination could have
occurred, artefactually affecting the laboratory sodium
result
Neville 2010
Methods Randomised controlled trial
Participants 147 children undergoing elective or emergency surgery
Interventions 0.9% saline + 2.5% dextrose at standard maintenance rate
0.9% saline + 5% dextrose at 50% maintenance rate
0.45% saline + 2.5% dextrose at standard maintenance rate
0.45% saline + 5% dextrose at 50% maintenance
Outcomes Change in plasma sodium from induction of anaesthesia to T8 and rates of hypona-
traemia
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Not computer-generated, but opaque envelopes in com-
pletely random order
Allocation concealment (selection bias) Low risk Sequential selection of an opaque, sealed envelope con-
taining the fluid choice in a random order
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Not blinded, but primary outcome objective
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Neville 2010 (Continued)
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Not blinded, but primary outcome objective
Incomplete outcome data (attrition bias)
All outcomes
Low risk 84% analysed, similar proportion in each group. Well
explained
Selective reporting (reporting bias) Unclear risk Protocol not registered
Other bias Unclear risk Method of blood sampling not described. If blood was
taken from the same IV line into which the study fluid
was administered, potential contamination could have
occurred, artefactually affecting the laboratory sodium
result
Rey 2011
Methods Randomised controlled trial
Participants 134 paediatric intensive care unit patients
Interventions Isotonic (sodium 136 mmol/L)
Hypotonic (sodium 30 to 50 mmol/L)
Exact composition not stated
Rate: standard maintenance
Outcomes Change in plasma sodium from admission to 12 and 24 hours later
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Patient group assignment was previously made using the
random number generator of the free software R.10.0
(www.r-project.org). Random seed was initialised by the
particular date
Allocation concealment (selection bias) Unclear risk Not described
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Not blinded, but primary outcome objective
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Not blinded, but primary outcome objective
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Rey 2011 (Continued)
Incomplete outcome data (attrition bias)
All outcomes
Low risk 93% analysed
Selective reporting (reporting bias) Low risk Registered protocol
Other bias Unclear risk Method of blood sampling not described. If blood was
taken from the same IV line into which the study fluid
was administered, potential contamination could have
occurred, artefactually affecting the laboratory sodium
result
Saba 2011
Methods Randomised controlled trial
Participants 59 patients including medical patients admitted via the Emergency Department and
elective surgical patients
Interventions 0.9% saline + 5% dextrose
0.45% saline + 5% dextrose
Rate: physician’s discretion
Outcomes Rate of change of sodium
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Stratified by admission type (medical versus surgical),
carried out in blocks of 6 using a computerised random
number generator
Allocation concealment (selection bias) Unclear risk Not described
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Participants, the treating team and the research teamwere
blinded - solutions covered with opaque plastic covering
by the pharmacist
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Not blinded, but primary outcome objective
Incomplete outcome data (attrition bias)
All outcomes
High risk Planned to enrol 25 patients per group, only 16 and 21
completed. Also, large “declined to participate” numbers
(83/142)
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Saba 2011 (Continued)
Selective reporting (reporting bias) Low risk Registered protocol
Other bias Unclear risk Method of blood sampling not described. If blood was
taken from the same IV line into which the study fluid
was administered, potential contamination could have
occurred, artefactually affecting the laboratory sodium
result
Yung 2009
Methods Randomised controlled trial
Participants 53 paediatric intensive care unit patients
Interventions 0.9% saline at standard maintenance rate
0.9% saline at 2/3 maintenance rate
0.18% saline + 4% dextrose at standard maintenance rate
0.18% saline + 4% dextrose at 2/3 maintenance rate
Outcomes Change in plasma sodium from admission to 12 to 24 hours later
Notes -
Risk of bias
Bias Authors’ judgement Support for judgement
Random sequence generation (selection
bias)
Low risk Random numbers using blocks of 6
Allocation concealment (selection bias) Low risk Fluids and rate kept in sealed box
Blinding of participants and personnel
(performance bias)
All outcomes
Low risk Blinded to type but not rate. Primary outcome objective
Blinding of outcome assessment (detection
bias)
All outcomes
Low risk Not blinded, but primary outcome objective
Incomplete outcome data (attrition bias)
All outcomes
Low risk 94% analysed
Selective reporting (reporting bias) Low risk Registered protocol
Other bias Unclear risk Method of blood sampling not described. If blood was
taken from the same IV line into which the study fluid
was administered, potential contamination could have
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Yung 2009 (Continued)
occurred, artefactually affecting the laboratory sodium
result
hr: hour
IV: intravenous
SIADH: syndrome of inappropriate antidiuretic hormone secretion
Characteristics of excluded studies [ordered by study ID]
Study Reason for exclusion
Ang 2010 Published only as a conference abstract. Insufficient detail available
Da li 1997 Predominantly examined intraoperative fluid replacement rather than maintenance hydration
Flaring 2011 Study published only in protocol form. Contact with the researchers indicated that the study has been ceased due to
insufficient recruitment
Neville 2006 Intravenous fluids primarily given to replace a pre-existing deficit rather than for maintenance hydration
Characteristics of studies awaiting assessment [ordered by study ID]
Baron 2013
Methods Blinded randomised controlled trial
Participants 63 intensive care patients
Interventions 0.9% sodium chloride + 5% dextrose
0.45% sodium chloride + 5% dextrose
(maintenance rates)
Outcomes Change in sodium between baseline and after maintenance infusion was ceased
Notes Published after our search was completed
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McNab 2014
Methods Blinded randomised controlled trial
Participants 690 hospitalised children requiring intravenous maintenance fluid
Interventions Plasmalyte148 + 5% dextrose
0.45% sodium chloride + 5% dextrose
Outcomes Proportion of patients developing hyponatraemia (serum sodium <135 mmol/L with a decrease of at least 3 mmol/
L compared with baseline)
Notes Published after our search was completed
Pemde 2014
Methods Blinded randomised controlled trial (3 armed)
Participants 92 patients aged 3 months to 5 years with suspected central nervous system infections
Interventions 0.9% sodium chloride + 5% dextrose
0.45% sodium chloride + 5% dextrose
0.18% sodium chloride + 5% dextrose
(maintenance rates)
Outcomes Proportion of patients developing hyponatremia (serum sodium<135 mmol/L) after 24 h and serum sodium values
at 6, 12, 18, 24 h of receiving maintenance fluids
Notes Published after our search was completed
Characteristics of ongoing studies [ordered by study ID]
CTRI/2010/091/000398
Trial name or title Randomised controlled trial comparing isotonic and hypotonic intravenous fluids for maintenance fluid
therapy in children
Registration ID: CTRI/2010/091/000398
Methods
Participants 60 children
Interventions 0.9% sodium chloride + 5% dextrose at 60% maintenance rate
0.18% sodium chloride + 5% dextrose at 100% maintenance rate
Outcomes Incidence of hyponatraemia 24 and 48 hours after initiating intervention
Starting date
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CTRI/2010/091/000398 (Continued)
Contact information
Notes
NCT00632775
Trial name or title Randomised, double-blind, controlled trial of 0.9% NaCl/dextrose 5% versus 0.45% NaCl/dextrose 5% as
maintenance intravenous fluids in hospitalised children
Registration ID: NCT00632775
Methods
Participants 110 children
Interventions 0.9% sodium chloride + 5% dextrose
0.45% sodium chloride + 5% dextrose
(maintenance rates)
Outcomes Plasma urea, creatinine, glucose and electrolyte levels at the time of IV start and every 24 hours thereafter
Starting date December 2007
Contact information
Notes
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D A T A A N D A N A L Y S E S
Comparison 1. Isotonic versus hypotonic
Outcome or subgroup title
No. of
studies
No. of
participants Statistical method Effect size
1 Hyponatraemia 10 970 Risk Ratio (M-H, Fixed, 95% CI) 0.48 [0.38, 0.60]
2 Hypernatraemia 9 937 Risk Ratio (M-H, Fixed, 95% CI) 1.24 [0.65, 2.38]
3 Mean serum sodium T6-T12 7 851 Mean Difference (IV, Fixed, 95% CI) 1.99 [1.55, 2.42]
4 Mean serum sodium at T > T12
to T24
6 579 Mean Difference (IV, Fixed, 95% CI) 1.33 [0.81, 1.85]
5 Death 10 996 Risk Ratio (M-H, Fixed, 95% CI) 5.59 [0.23, 135.17]
6 Seizures 10 996 Risk Ratio (M-H, Fixed, 95% CI) 0.62 [0.03, 15.02]
7 Cerebral oedema 9 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
8 Overhydration 5 615 Risk Ratio (M-H, Fixed, 95% CI) 1.14 [0.46, 2.87]
9 Urine osmolarity at T24 3 278 Mean Difference (IV, Fixed, 95% CI) 12.68 [-34.20, 59.
56]
10 Urinary sodium concentration
at T24
4 516 Mean Difference (IV, Fixed, 95% CI) 14.72 [9.02, 20.42]
11 Hyponatraemia (by
concentration of hypotonic
fluid)
9 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
11.1 Isotonic versus
moderately hypotonic fluid
4 458 Risk Ratio (M-H, Fixed, 95% CI) 0.48 [0.34, 0.67]
11.2 Isotonic versus very
hypotonic fluid
5 409 Risk Ratio (M-H, Fixed, 95% CI) 0.40 [0.27, 0.58]
12 Hyponatraemia
(surgical/medical)
8 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
12.1 Surgical patients 7 529 Risk Ratio (M-H, Fixed, 95% CI) 0.48 [0.36, 0.64]
12.2 Medical patients 4 279 Risk Ratio (M-H, Fixed, 95% CI) 0.29 [0.16, 0.55]
13 Hyponatraemia (by fluid rate) 5 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
13.1 Full maintenance 5 459 Risk Ratio (M-H, Fixed, 95% CI) 0.45 [0.33, 0.61]
13.2 Restricted rate 1 62 Risk Ratio (M-H, Fixed, 95% CI) 0.45 [0.18, 1.16]
14 Hyponatraemia (by age) 8 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
14.1 Age < 1 year 7 100 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.12, 0.88]
14.2 Age 1 to 5 years 7 243 Risk Ratio (M-H, Fixed, 95% CI) 0.33 [0.19, 0.57]
14.3 Age > 5 years 8 465 Risk Ratio (M-H, Fixed, 95% CI) 0.51 [0.38, 0.69]
15 Hyponatraemia (by severity of
illness)
9 Risk Ratio (M-H, Fixed, 95% CI) Subtotals only
15.1 Intensive care patients 5 443 Risk Ratio (M-H, Fixed, 95% CI) 0.48 [0.37, 0.64]
15.2 Non-intensive care
patients
5 359 Risk Ratio (M-H, Fixed, 95% CI) 0.45 [0.29, 0.68]
16 Sensitivity analysis - balanced
fluid rates
8 735 Risk Ratio (M-H, Fixed, 95% CI) 0.45 [0.35, 0.58]
17 Sensitivity analysis -
normonatraemic at baseline
4 326 Risk Ratio (M-H, Fixed, 95% CI) 0.49 [0.34, 0.71]
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Analysis 1.1. Comparison 1 Isotonic versus hypotonic, Outcome 1 Hyponatraemia.
Review: Isotonic versus hypotonic solutions for maintenance intravenous fluid administration in children
Comparison: 1 Isotonic versus hypotonic
Outcome: 1 Hyponatraemia
Study or subgroup Isotonic Hypotonic Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Brazel 1996 1/5 7/7 3.8 % 0.27 [ 0.07, 1.08 ]
Choong 2011 26/106 47/112 27.1 % 0.58 [ 0.39, 0.87 ]
Coulthard 2012 0/39 7/40 4.4 % 0.07 [ 0.00, 1.16 ]
Cuello 2012 0/20 8/26 4.4 % 0.08 [ 0.00, 1.24 ]
Kannan 2010 5/58 18/109 7.4 % 0.52 [ 0.20, 1.33 ]
Monta ana 2008 15/51 20/52 11.7 % 0.76 [ 0.44, 1.32 ]
Neville 2010 9/62 23/62 13.6 % 0.39 [ 0.20, 0.78 ]
Rey 2011 17/68 39/66 23.4 % 0.42 [ 0.27, 0.67 ]
Saba 2011 0/16 1/21 0.8 % 0.43 [ 0.02, 9.94 ]
Yung 2009 3/24 6/26 3.4 % 0.54 [ 0.15, 1.93 ]
Total (95% CI) 449 521 100.0 % 0.48 [ 0.38, 0.60 ]
Total events: 76 (Isotonic), 176 (Hypotonic)
Heterogeneity: Chi2 = 8.67, df = 9 (P = 0.47); I2 =0.0%
Test for overall effect: Z = 6.34 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 1.2. Comparison 1 Isotonic versus hypotonic, Outcome 2 Hypernatraemia.
Review: Isotonic versus hypotonic solutions for maintenance intravenous fluid administration in children
Comparison: 1 Isotonic versus hypotonic
Outcome: 2 Hypernatraemia
Study or subgroup Isotonic Hypotonic Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Brazel 1996 0/5 0/7 Not estimable
Choong 2011 3/106 4/112 25.0 % 0.79 [ 0.18, 3.46 ]
Coulthard 2012 0/39 0/40 Not estimable
Cuello 2012 0/37 0/35 Not estimable
Kannan 2010 5/58 9/109 40.2 % 1.04 [ 0.37, 2.97 ]
Monta ana 2008 2/51 4/52 25.5 % 0.51 [ 0.10, 2.66 ]
Neville 2010 4/62 0/62 3.2 % 9.00 [ 0.49, 163.70 ]
Rey 2011 1/63 0/62 3.2 % 2.95 [ 0.12, 71.13 ]
Saba 2011 1/16 0/21 2.8 % 3.88 [ 0.17, 89.46 ]
Total (95% CI) 437 500 100.0 % 1.24 [ 0.65, 2.38 ]
Total events: 16 (Isotonic), 17 (Hypotonic)
Heterogeneity: Chi2 = 4.16, df = 5 (P = 0.53); I2 =0.0%
Test for overall effect: Z = 0.66 (P = 0.51)
Test for subgroup differences: Not applicable
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Analysis 1.3. Comparison 1 Isotonic versus hypotonic, Outcome 3 Mean serum sodium T6-T12.
Review: Isotonic versus hypotonic solutions for maintenance intravenous fluid administration in children
Comparison: 1 Isotonic versus hypotonic
Outcome: 3 Mean serum sodium T6-T12
Study or subgroup Isotonic Hypotonic
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Monta ana 2008 51 137.1 (3.7) 52 136.4 (6.8) 4.2 % 0.70 [ -1.41, 2.81 ]
Kannan 2010 58 139.8 (3.3) 109 138.4 (3.7) 15.6 % 1.40 [ 0.30, 2.50 ]
Saba 2011 16 139.7 (3) 21 138 (2.4) 5.8 % 1.70 [ -0.09, 3.49 ]
Choong 2011 112 138 (3.14) 111 136.2 (3.29) 26.3 % 1.80 [ 0.96, 2.64 ]
Neville 2010 62 138 (2.85) 62 136 (2.08) 24.3 % 2.00 [ 1.12, 2.88 ]
Cuello 2012 37 138.8 (3.3) 35 136.4 (3.3) 8.1 % 2.40 [ 0.87, 3.93 ]
Rey 2011 63 136.8 (3.5) 62 133.7 (2.7) 15.7 % 3.10 [ 2.01, 4.19 ]
Total (95% CI) 399 452 100.0 % 1.99 [ 1.55, 2.42 ]
Heterogeneity: Chi2 = 7.07, df = 6 (P = 0.31); I2 =15%
Test for overall effect: Z = 8.99 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 1.4. Comparison 1 Isotonic versus hypotonic, Outcome 4 Mean serum sodium at T > T12 to T24.
Review: Isotonic versus hypotonic solutions for maintenance intravenous fluid administration in children
Comparison: 1 Isotonic versus hypotonic
Outcome: 4 Mean serum sodium at T > T12 to T24
Study or subgroup Isotonic Hypotonic
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Choong 2011 77 139.3 (3.4) 80 138.6 (2.8) 28.2 % 0.70 [ -0.28, 1.68 ]
Coulthard 2012 39 138.1 (1.9) 40 136.7 (2.7) 25.5 % 1.40 [ 0.37, 2.43 ]
Kannan 2010 56 140.3 (3.7) 107 139.3 (5.7) 12.8 % 1.00 [ -0.45, 2.45 ]
Monta ana 2008 23 138.9 (3.6) 23 136.2 (5.2) 4.0 % 2.70 [ 0.12, 5.28 ]
Neville 2010 31 137.2 (3.44) 36 136 (2.02) 14.1 % 1.20 [ -0.18, 2.58 ]
Rey 2011 35 136.6 (3.1) 32 134.2 (2.4) 15.4 % 2.40 [ 1.08, 3.72 ]
Total (95% CI) 261 318 100.0 % 1.33 [ 0.81, 1.85 ]
Heterogeneity: Chi2 = 5.45, df = 5 (P = 0.36); I2 =8%
Test for overall effect: Z = 5.03 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 1.5. Comparison 1 Isotonic versus hypotonic, Outcome 5 Death.
Review: Isotonic versus hypotonic solutions for maintenance intravenous fluid administration in children
Comparison: 1 Isotonic versus hypotonic
Outcome: 5 Death
Study or subgroup Isotonic Hypotonic Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Brazel 1996 0/5 0/7 Not estimable
Choong 2011 0/106 0/112 Not estimable
Coulthard 2012 0/39 0/40 Not estimable
Cuello 2012 0/37 0/35 Not estimable
Kannan 2010 1/58 0/109 100.0 % 5.59 [ 0.23, 135.17 ]
Monta ana 2008 0/51 0/52 Not estimable
Neville 2010 0/62 0/62 Not estimable
Rey 2011 0/68 0/66 Not estimable
Saba 2011 0/16 0/21 Not estimable
Yung 2009 0/24 0/26 Not estimable
Total (95% CI) 466 530 100.0 % 5.59 [ 0.23, 135.17 ]
Total events: 1 (Isotonic), 0 (Hypotonic)
Heterogeneity: not applicable
Test for overall effect: Z = 1.06 (P = 0.29)
Test for subgroup differences: Not applicable
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Analysis 1.6. Comparison 1 Isotonic versus hypotonic, Outcome 6 Seizures.
Review: Isotonic versus hypotonic solutions for maintenance intravenous fluid administration in children
Comparison: 1 Isotonic versus hypotonic
Outcome: 6 Seizures
Study or subgroup Isotonic Hypotonic Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Brazel 1996 0/5 0/7 Not estimable
Choong 2011 0/106 0/112 Not estimable
Coulthard 2012 0/39 0/40 Not estimable
Cuello 2012 0/37 0/35 Not estimable
Kannan 2010 0/58 1/109 100.0 % 0.62 [ 0.03, 15.02 ]
Monta ana 2008 0/51 0/52 Not estimable
Neville 2010 0/62 0/62 Not estimable
Rey 2011 0/68 0/66 Not estimable
Saba 2011 0/16 0/21 Not estimable
Yung 2009 0/24 0/26 Not estimable
Total (95% CI) 466 530 100.0 % 0.62 [ 0.03, 15.02 ]
Total events: 0 (Isotonic), 1 (Hypotonic)
Heterogeneity: not applicable
Test for overall effect: Z = 0.29 (P = 0.77)
Test for subgroup differences: Not applicable
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Analysis 1.7. Comparison 1 Isotonic versus hypotonic, Outcome 7 Cerebral oedema.
Review: Isotonic versus hypotonic solutions for maintenance intravenous fluid administration in children
Comparison: 1 Isotonic versus hypotonic
Outcome: 7 Cerebral oedema
Study or subgroup Isotonic Hypotonic Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Brazel 1996 0/5 0/7 Not estimable
Choong 2011 0/106 0/112 Not estimable
Coulthard 2012 0/39 0/40 Not estimable
Cuello 2012 0/37 0/35 Not estimable
Monta ana 2008 0/51 0/52 Not estimable
Neville 2010 0/62 0/62 Not estimable
Rey 2011 0/68 0/66 Not estimable
Saba 2011 0/16 0/21 Not estimable
Yung 2009 0/24 0/26 Not estimable
Test for subgroup differences: Not applicable
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Analysis 1.8. Comparison 1 Isotonic versus hypotonic, Outcome 8 Overhydration.
Review: Isotonic versus hypotonic solutions for maintenance intravenous fluid administration in children
Comparison: 1 Isotonic versus hypotonic
Outcome: 8 Overhydration
Study or subgroup Isotonic Hypotonic Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Choong 2011 9/128 8/130 100.0 % 1.14 [ 0.46, 2.87 ]
Cuello 2012 0/37 0/35 Not estimable
Kannan 2010 0/58 0/56 Not estimable
Rey 2011 0/68 0/66 Not estimable
Saba 2011 0/16 0/21 Not estimable
Total (95% CI) 307 308 100.0 % 1.14 [ 0.46, 2.87 ]
Total events: 9 (Isotonic), 8 (Hypotonic)
Heterogeneity: not applicable
Test for overall effect: Z = 0.28 (P = 0.78)
Test for subgroup differences: Not applicable
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Analysis 1.9. Comparison 1 Isotonic versus hypotonic, Outcome 9 Urine osmolarity at T24.
Review: Isotonic versus hypotonic solutions for maintenance intravenous fluid administration in children
Comparison: 1 Isotonic versus hypotonic
Outcome: 9 Urine osmolarity at T24
Study or subgroup Isotonic Hypotonic
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Coulthard 2012 39 634.7 (245.1) 40 605.2 (249.9) 18.4 % 29.50 [ -79.65, 138.65 ]
Kannan 2010 31 516.8 (154.7) 56 498.4 (166.1) 45.2 % 18.40 [ -51.30, 88.10 ]
Neville 2010 56 747.5 (213.8) 56 750.5 (206.2) 36.3 % -3.00 [ -80.80, 74.80 ]
Total (95% CI) 126 152 100.0 % 12.68 [ -34.20, 59.56 ]
Heterogeneity: Chi2 = 0.27, df = 2 (P = 0.87); I2 =0.0%
Test for overall effect: Z = 0.53 (P = 0.60)
Test for subgroup differences: Not applicable
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Analysis 1.10. Comparison 1 Isotonic versus hypotonic, Outcome 10 Urinary sodium concentration at T24.
Review: Isotonic versus hypotonic solutions for maintenance intravenous fluid administration in children
Comparison: 1 Isotonic versus hypotonic
Outcome: 10 Urinary sodium concentration at T24
Study or subgroup Isotonic Hypotonic
Mean
Difference Weight
Mean
Difference
N Mean(SD) N Mean(SD) IV,Fixed,95% CI IV,Fixed,95% CI
Choong 2011 125 156.8 (64.7) 113 89 (58.3) 13.3 % 67.80 [ 52.17, 83.43 ]
Coulthard 2012 39 136.6 (76.8) 40 113.8 (73.7) 2.9 % 22.80 [ -10.41, 56.01 ]
Kannan 2010 31 42.8 (16.7) 56 38.7 (11.1) 75.5 % 4.10 [ -2.46, 10.66 ]
Neville 2010 56 126.5 (57.84) 56 103 (49.3) 8.2 % 23.50 [ 3.59, 43.41 ]
Total (95% CI) 251 265 100.0 % 14.72 [ 9.02, 20.42 ]
Heterogeneity: Chi2 = 55.37, df = 3 (P<0.00001); I2 =95%
Test for overall effect: Z = 5.06 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 1.11. Comparison 1 Isotonic versus hypotonic, Outcome 11 Hyponatraemia (by concentration of
hypotonic fluid).
Review: Isotonic versus hypotonic solutions for maintenance intravenous fluid administration in children
Comparison: 1 Isotonic versus hypotonic
Outcome: 11 Hyponatraemia (by concentration of hypotonic fluid)
Study or subgroup Isotonic Hypotonic Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Isotonic versus moderately hypotonic fluid
Choong 2011 26/106 47/112 59.0 % 0.58 [ 0.39, 0.87 ]
Coulthard 2012 0/39 7/40 9.6 % 0.07 [ 0.00, 1.16 ]
Neville 2010 9/62 23/62 29.7 % 0.39 [ 0.20, 0.78 ]
Saba 2011 0/16 1/21 1.7 % 0.43 [ 0.02, 9.94 ]
Subtotal (95% CI) 223 235 100.0 % 0.48 [ 0.34, 0.67 ]
Total events: 35 (Isotonic), 78 (Hypotonic)
Heterogeneity: Chi2 = 3.15, df = 3 (P = 0.37); I2 =5%
Test for overall effect: Z = 4.29 (P = 0.000018)
2 Isotonic versus very hypotonic fluid
Brazel 1996 1/5 7/7 9.0 % 0.27 [ 0.07, 1.08 ]
Cuello 2012 0/20 8/26 10.4 % 0.08 [ 0.00, 1.24 ]
Kannan 2010 5/58 18/109 17.4 % 0.52 [ 0.20, 1.33 ]
Rey 2011 17/68 39/66 55.2 % 0.42 [ 0.27, 0.67 ]
Yung 2009 3/24 6/26 8.0 % 0.54 [ 0.15, 1.93 ]
Subtotal (95% CI) 175 234 100.0 % 0.40 [ 0.27, 0.58 ]
Total events: 26 (Isotonic), 78 (Hypotonic)
Heterogeneity: Chi2 = 2.28, df = 4 (P = 0.69); I2 =0.0%
Test for overall effect: Z = 4.75 (P < 0.00001)
Test for subgroup differences: Chi2 = 0.44, df = 1 (P = 0.51), I2 =0.0%
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Analysis 1.12. Comparison 1 Isotonic versus hypotonic, Outcome 12 Hyponatraemia (surgical/medical).
Review: Isotonic versus hypotonic solutions for maintenance intravenous fluid administration in children
Comparison: 1 Isotonic versus hypotonic
Outcome: 12 Hyponatraemia (surgical/medical)
Study or subgroup Isotonic Hypotonic Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Surgical patients
Brazel 1996 1/5 7/7 6.3 % 0.27 [ 0.07, 1.08 ]
Choong 2011 26/106 47/112 44.6 % 0.58 [ 0.39, 0.87 ]
Coulthard 2012 0/39 7/40 7.2 % 0.07 [ 0.00, 1.16 ]
Cuello 2012 0/6 3/8 3.0 % 0.18 [ 0.01, 3.00 ]
Neville 2010 9/62 23/62 22.4 % 0.39 [ 0.20, 0.78 ]
Rey 2011 12/32 14/25 15.3 % 0.67 [ 0.38, 1.18 ]
Saba 2011 0/10 1/15 1.2 % 0.48 [ 0.02, 10.84 ]
Subtotal (95% CI) 260 269 100.0 % 0.48 [ 0.36, 0.64 ]
Total events: 48 (Isotonic), 102 (Hypotonic)
Heterogeneity: Chi2 = 5.49, df = 6 (P = 0.48); I2 =0.0%
Test for overall effect: Z = 4.97 (P < 0.00001)
2 Medical patients
Cuello 2012 0/14 5/18 12.4 % 0.12 [ 0.01, 1.92 ]
Kannan 2010 5/58 18/109 31.9 % 0.52 [ 0.20, 1.33 ]
Rey 2011 4/31 24/37 55.8 % 0.20 [ 0.08, 0.51 ]
Saba 2011 0/6 0/6 Not estimable
Subtotal (95% CI) 109 170 100.0 % 0.29 [ 0.16, 0.55 ]
Total events: 9 (Isotonic), 47 (Hypotonic)
Heterogeneity: Chi2 = 2.53, df = 2 (P = 0.28); I2 =21%
Test for overall effect: Z = 3.83 (P = 0.00013)
Test for subgroup differences: Chi2 = 2.06, df = 1 (P = 0.15), I2 =51%
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Analysis 1.13. Comparison 1 Isotonic versus hypotonic, Outcome 13 Hyponatraemia (by fluid rate).
Review: Isotonic versus hypotonic solutions for maintenance intravenous fluid administration in children
Comparison: 1 Isotonic versus hypotonic
Outcome: 13 Hyponatraemia (by fluid rate)
Study or subgroup Isotonic Hypotonic Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Full maintenance
Cuello 2012 0/20 8/26 8.1 % 0.08 [ 0.00, 1.24 ]
Kannan 2010 5/58 13/56 14.4 % 0.37 [ 0.14, 0.97 ]
Monta ana 2008 15/51 20/52 21.5 % 0.76 [ 0.44, 1.32 ]
Neville 2010 4/31 12/31 13.0 % 0.33 [ 0.12, 0.92 ]
Rey 2011 17/68 39/66 43.0 % 0.42 [ 0.27, 0.67 ]
Subtotal (95% CI) 228 231 100.0 % 0.45 [ 0.33, 0.61 ]
Total events: 41 (Isotonic), 92 (Hypotonic)
Heterogeneity: Chi2 = 5.74, df = 4 (P = 0.22); I2 =30%
Test for overall effect: Z = 5.02 (P < 0.00001)
2 Restricted rate
Neville 2010 5/31 11/31 100.0 % 0.45 [ 0.18, 1.16 ]
Subtotal (95% CI) 31 31 100.0 % 0.45 [ 0.18, 1.16 ]
Total events: 5 (Isotonic), 11 (Hypotonic)
Heterogeneity: not applicable
Test for overall effect: Z = 1.66 (P = 0.098)
Test for subgroup differences: Chi2 = 0.00, df = 1 (P = 0.98), I2 =0.0%
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Analysis 1.14. Comparison 1 Isotonic versus hypotonic, Outcome 14 Hyponatraemia (by age).
Review: Isotonic versus hypotonic solutions for maintenance intravenous fluid administration in children
Comparison: 1 Isotonic versus hypotonic
Outcome: 14 Hyponatraemia (by age)
Study or subgroup Isotonic Hypotonic Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Age < 1 year
Choong 2011 0/7 1/8 10.2 % 0.38 [ 0.02, 7.96 ]
Coulthard 2012 0/5 1/6 10.1 % 0.39 [ 0.02, 7.88 ]
Cuello 2012 0/4 0/3 Not estimable
Kannan 2010 1/13 8/26 38.7 % 0.25 [ 0.03, 1.79 ]
Neville 2010 0/5 0/1 Not estimable
Rey 2011 2/8 6/9 41.0 % 0.38 [ 0.10, 1.36 ]
Saba 2011 0/3 0/2 Not estimable
Subtotal (95% CI) 45 55 100.0 % 0.33 [ 0.12, 0.88 ]
Total events: 3 (Isotonic), 16 (Hypotonic)
Heterogeneity: Chi2 = 0.13, df = 3 (P = 0.99); I2 =0.0%
Test for overall effect: Z = 2.21 (P = 0.027)
2 Age 1 to 5 years
Choong 2011 4/24 11/26 25.4 % 0.39 [ 0.14, 1.07 ]
Coulthard 2012 0/8 0/3 Not estimable
Cuello 2012 0/6 4/9 8.9 % 0.16 [ 0.01, 2.50 ]
Kannan 2010 4/28 6/52 10.1 % 1.24 [ 0.38, 4.02 ]
Neville 2010 0/13 8/17 17.9 % 0.08 [ 0.00, 1.20 ]
Rey 2011 3/24 16/25 37.7 % 0.20 [ 0.07, 0.59 ]
Saba 2011 0/2 0/6 Not estimable
Subtotal (95% CI) 105 138 100.0 % 0.33 [ 0.19, 0.57 ]
Total events: 11 (Isotonic), 45 (Hypotonic)
Heterogeneity: Chi2 = 7.23, df = 4 (P = 0.12); I2 =45%
Test for overall effect: Z = 3.88 (P = 0.00011)
3 Age > 5 years
Brazel 1996 1/5 7/7 7.3 % 0.27 [ 0.07, 1.08 ]
Choong 2011 22/75 35/78 39.0 % 0.65 [ 0.43, 1.00 ]
Coulthard 2012 0/26 6/31 6.8 % 0.09 [ 0.01, 1.55 ]
Cuello 2012 0/10 4/14 4.3 % 0.15 [ 0.01, 2.53 ]
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(. . . Continued)
Study or subgroup Isotonic Hypotonic Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Kannan 2010 0/17 4/31 3.7 % 0.20 [ 0.01, 3.46 ]
Neville 2010 9/44 15/44 17.0 % 0.60 [ 0.29, 1.22 ]
Rey 2011 10/31 17/28 20.3 % 0.53 [ 0.29, 0.96 ]
Saba 2011 0/11 1/13 1.6 % 0.39 [ 0.02, 8.69 ]
Subtotal (95% CI) 219 246 100.0 % 0.51 [ 0.38, 0.69 ]
Total events: 42 (Isotonic), 89 (Hypotonic)
Heterogeneity: Chi2 = 4.91, df = 7 (P = 0.67); I2 =0.0%
Test for overall effect: Z = 4.37 (P = 0.000012)
Test for subgroup differences: Chi2 = 2.30, df = 2 (P = 0.32), I2 =13%
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Analysis 1.15. Comparison 1 Isotonic versus hypotonic, Outcome 15 Hyponatraemia (by severity of illness).
Review: Isotonic versus hypotonic solutions for maintenance intravenous fluid administration in children
Comparison: 1 Isotonic versus hypotonic
Outcome: 15 Hyponatraemia (by severity of illness)
Study or subgroup Isotonic Hypotonic Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
1 Intensive care patients
Choong 2011 13/39 27/38 27.4 % 0.47 [ 0.29, 0.76 ]
Coulthard 2012 0/39 7/40 7.4 % 0.07 [ 0.00, 1.16 ]
Monta ana 2008 15/51 20/52 19.8 % 0.76 [ 0.44, 1.32 ]
Rey 2011 17/68 39/66 39.6 % 0.42 [ 0.27, 0.67 ]
Yung 2009 3/24 6/26 5.8 % 0.54 [ 0.15, 1.93 ]
Subtotal (95% CI) 221 222 100.0 % 0.48 [ 0.37, 0.64 ]
Total events: 48 (Isotonic), 99 (Hypotonic)
Heterogeneity: Chi2 = 4.91, df = 4 (P = 0.30); I2 =18%
Test for overall effect: Z = 5.13 (P < 0.00001)
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(. . . Continued)
Study or subgroup Isotonic Hypotonic Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
2 Non-intensive care patients
Brazel 1996 1/5 7/7 11.2 % 0.27 [ 0.07, 1.08 ]
Choong 2011 13/67 20/74 33.2 % 0.72 [ 0.39, 1.33 ]
Cuello 2012 0/20 8/26 13.0 % 0.08 [ 0.00, 1.24 ]
Neville 2010 9/62 23/62 40.2 % 0.39 [ 0.20, 0.78 ]
Saba 2011 0/16 1/20 2.3 % 0.41 [ 0.02, 9.48 ]
Subtotal (95% CI) 170 189 100.0 % 0.45 [ 0.29, 0.68 ]
Total events: 23 (Isotonic), 59 (Hypotonic)
Heterogeneity: Chi2 = 4.52, df = 4 (P = 0.34); I2 =11%
Test for overall effect: Z = 3.78 (P = 0.00016)
Test for subgroup differences: Chi2 = 0.11, df = 1 (P = 0.75), I2 =0.0%
0.01 0.1 1 10 100
Favours isotonic Favours hypotonic
49Isotonic versus hypotonic solutions for maintenance intravenous fluid administration in children (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
Analysis 1.16. Comparison 1 Isotonic versus hypotonic, Outcome 16 Sensitivity analysis - balanced fluid
rates.
Review: Isotonic versus hypotonic solutions for maintenance intravenous fluid administration in children
Comparison: 1 Isotonic versus hypotonic
Outcome: 16 Sensitivity analysis - balanced fluid rates
Study or subgroup Isotonic Hypotonic Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Brazel 1996 1/5 7/7 4.6 % 0.27 [ 0.07, 1.08 ]
Choong 2011 26/106 47/112 32.6 % 0.58 [ 0.39, 0.87 ]
Cuello 2012 0/20 8/26 5.3 % 0.08 [ 0.00, 1.24 ]
Kannan 2010 5/58 13/56 9.4 % 0.37 [ 0.14, 0.97 ]
Neville 2010 9/62 23/62 16.4 % 0.39 [ 0.20, 0.78 ]
Rey 2011 16/66 38/68 26.7 % 0.43 [ 0.27, 0.70 ]
Saba 2011 0/16 1/21 0.9 % 0.43 [ 0.02, 9.94 ]
Yung 2009 3/24 6/26 4.1 % 0.54 [ 0.15, 1.93 ]
Total (95% CI) 357 378 100.0 % 0.45 [ 0.35, 0.58 ]
Total events: 60 (Isotonic), 143 (Hypotonic)
Heterogeneity: Chi2 = 4.20, df = 7 (P = 0.76); I2 =0.0%
Test for overall effect: Z = 6.14 (P < 0.00001)
Test for subgroup differences: Not applicable
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Analysis 1.17. Comparison 1 Isotonic versus hypotonic, Outcome 17 Sensitivity analysis - normonatraemic
at baseline.
Review: Isotonic versus hypotonic solutions for maintenance intravenous fluid administration in children
Comparison: 1 Isotonic versus hypotonic
Outcome: 17 Sensitivity analysis - normonatraemic at baseline
Study or subgroup Isotonic Hypotonic Risk Ratio Weight Risk Ratio
n/N n/N M-H,Fixed,95% CI M-H,Fixed,95% CI
Brazel 1996 1/5 7/7 9.8 % 0.27 [ 0.07, 1.08 ]
Choong 2011 26/106 47/112 70.0 % 0.58 [ 0.39, 0.87 ]
Cuello 2012 0/20 8/26 11.4 % 0.08 [ 0.00, 1.24 ]
Yung 2009 3/24 6/26 8.8 % 0.54 [ 0.15, 1.93 ]
Total (95% CI) 155 171 100.0 % 0.49 [ 0.34, 0.71 ]
Total events: 30 (Isotonic), 68 (Hypotonic)
Heterogeneity: Chi2 = 3.21, df = 3 (P = 0.36); I2 =6%
Test for overall effect: Z = 3.83 (P = 0.00013)
Test for subgroup differences: Not applicable
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A D D I T I O N A L T A B L E S
Table 1. Common commercially available intravenous fluids
Na+
(mmol/L)
Cl-
(mmol/L)
K+
(mmol/L)
Mg++
(mmol/L)
Calcium
(mmol/L)
Lactate
(mmol/L)
Acetate
(mmol/L)
Gluconate
(mmol/L)
Glucose
(gram/L)
Physiolog-
ically iso-
tonic/near
isotonic
0.9%
sodium
chloride
154 154 - - - - - - -
0.9%
sodium
chlo-
ridewith 2.
5/5% dex-
trose
154 154 - - - - - - 25 / 50
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Table 1. Common commercially available intravenous fluids (Continued)
Hart-
mann’s so-
lution
(similar in
ionic com-
position to
Ringer’s
lactate)
131 111 5 - 2 29 - - -
Plas-
malyte 148
solution
140 98 5 1.5 - - 27 23 -
Plasmalyte
148 so-
lution with
5%
dextrose
140 98 5 1.5 - - 27 23 50
Physiolog-
i-
cally mod-
erately hy-
potonic
0.45%
sodium
chloride
(N/2) with
5%
dextrose
77 77 - - - - - - 50
Physiolog-
ically very
hypotonic
0.3%
sodium
chloride
(N/3) with
3.3% dex-
trose
51 51 - - - - - - 33
0.18%
sodium
chloride
(N/5) with
4%
dextrose
30 30 - - - - - - 40
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Note: Minor variations in composition occur at the point of manufacture.
Table 2. Included studies
Study Number of participants Population Study arms Primary outcome
Brazel 1996 12 Patients undergoing pri-
mary corrective surgery
for idiopathic scoliosis
Isotonic (Hartmann’s)
Hypotonic (either 0.3%
saline + 3% dextrose or
0.18% saline + 4% dex-
trose)
Rate: 1.5 ml/kg/hr
Development of SIADH
Montañana 2008 122 PICU patients Isotonic fluid (sodium
140 mEq/L)
Hypotonic fluid
(sodium between 20 and
100 mEq/L correspond-
ing to 2 to 4 mEq/kg/24
hr)
Exact composition of
fluids not stated
Rate: standard mainte-
nance
Hyponatraemia < 135
mEq/L
Yung 2009 50 PICU patients 0.9% saline at standard
maintenance rate
0.9% saline at 2/3 re-
stricted rate
0.18% saline + 4% dex-
trose at standard mainte-
nance rate
0.18% saline + 4% dex-
trose at 2/3 restricted rate
Change in
plasma sodium from ad-
mission to 12 to 24 hrs
later
Kannan 2010 167 Broad paediatric popula-
tion (university hospital
in India)
0.9% saline + 5% dex-
trose at standard mainte-
nance rate
0.18% saline + 5% dex-
trose at standard mainte-
nance rate
0.18% saline + 5% dex-
trose at 2/3 restricted rate
Hyponatraemia <
130mEq/L
Neville 2010 124 Elective or emergency
surgery
0.9% saline + 2.5% dex-
trose at standard mainte-
nance rate
0.9% saline + 5% dex-
trose at 50% restricted
rate
Change in
plasma sodium from in-
duction of anaesthesia to
T8
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Table 2. Included studies (Continued)
0.45% saline + 2.
5% dextrose at standard
maintenance rate
0.45% saline + 5% dex-
trose at 50% restricted
rate
Rey 2011 125 PICU patients Isotonic (sodium 136
mmol/L)
Hypotonic (sodium 30
to 50 mmol/L)
Exact composition not
stated
Rate: standard mainte-
nance
Change in
plasma sodium from ad-
mission to 12 and 24 hrs
later
Choong 2011 258 Surgical patients 0.9% saline + 5% dex-
trose
0.45% saline + 5% dex-
trose
Rate: Physician’s discre-
tion
Hyponatraemia < 135
mmol/L
Saba 2011 37 Medical patients admit-
ted via ED
Elective surgical patients
0.9% saline + 5% dex-
trose
0.45% saline + 5% dex-
trose
Rate: physician’s discre-
tion
Rate of change of sodium
Coulthard 2012 82 Patients undergoing
spinal instrumentation,
craniotomy for brain tu-
mour resection or cranial
vault remodelling
Hartmann’s + 5% dex-
trose at full maintenance
rate
0.45% saline + 5% dex-
trose at 2/3 restricted rate
Mean plasma sodium 16
to 18 hrs postoperatively
Cuello 2012
(abstract only)
72 Participants with either
of 2 conditions:
a) gastroen-
teritis with moderate de-
hydration and unable to
tolerate fluids
b) chil-
dren requiring non-ur-
gent surgery and requir-
ing maintenance intra-
venous hydration during
their admission
0.9% saline + 5% dex-
trose +/- 20mmol/LKCl
0.2% saline + 5% dex-
trose +/- 20mmol/LKCl
Rate: standard mainte-
nance
Mean plasma sodium at
4 (T4) and 8 (T8) hours,
and the percentage of
patients who developed
hyponatraemia (> 125
mEq/L and < 135 mEq/
L)
ED: emergency department
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hr: hour
KCl: potassium choride
PICU: paediatric intensive care unit
SIADH: syndrome of inappropriate antidiuretic hormone secretion
Table 3. Timing of therapy and outcome measures
First author Duration of fluid therapy Timing of outcome measurements
Brazel Max 72 hrs End of procedure, T6, T24, T48, T72
Montañana Max 24 hrs T6, T24 (only T6 primary outcome data included in analysis)
Yung 12 to 24 hrs T12 to 24
Kannan Max 72 hrs T12, T24, T36, T48, T60, T72
Neville Max 24 hrs At intubation, T8, T24
Rey Max 24 hrs T12, T24
Choong Max 48 hrs T12, T24, T36, T48
Saba 8 to 12 hrs T12
Coulthard 16 to 18 hrs T16 to 18
Cuello 8 hrs T4, T8
hr: hour
Table 4. Inclusion and exclusion criteria
Primary author Inclusion criteria Exclusion criteria
Brazel Adolescent patients undergoing primary corrective
surgery for adolescent idiopathic scoliosis
-
Montañana PICU patients requiring maintenance intravenous fluid Chronic or acute kidney failure
Patients at risk of cerebral oedema (diabetic ketoacidosis
or craneoencephalic trauma)
Patients with plasma sodium level at admission < 130
mEq/L or > 150 mEq/L, and/or dehydration > 5% of
the patient’s body weight
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Table 4. Inclusion and exclusion criteria (Continued)
Yung Patients admitted to PICU who would normally require
IV fluids at standard maintenance rates for 12 hrs, with
normal sodium levels and not hypoglycaemic
Neonates, diabetes, renal failure, shock
Cardiac and neurosurgical patients were eligible for the
restricted rate arm only
Kannan Patients aged between 3 months and 12 years requiring
IV maintenance fluid administration for at least 24 hrs
Na < 130mEq/L, Na > 150mEq/L, blood glucose > 180
mg/dL, dehydration, shock, severemalnutrition, cirrho-
sis of liver, congestive heart failure, acute or chronic re-
nal failure and nephrotic syndrome
Patients receiving drugs that may alter plasma sodium
levels
Patients requiring fluid boluses for volume depletion
and/or shock
Neville Patients undergoing elective or emergency surgery, ex-
pected to take nothing by mouth after surgery for at
least 8 hrs. Weight > 8kg
Significant blood loss expected during surgery
Surgery types known to be associated with excess ADH
secretion (cranial and thoracic surgery)
Known abnormality of ADH secretion, nephrogenic di-
abetes insipidus, pituitary or hypothalamic disease, kid-
ney disease, acute or chronic lung disease
Patients receiving drugs known to stimulate ADH se-
cretion
Rey PICU patients requiring maintenance IV fluids Impairment in body water homeostasis (e.g. congestive
heart failure)
Electrolytic alterations requiring a different IV fluid
than that in the study
Renal function abnormalities
Patients requiring fluid restriction
Patients receiving enteral or parenteral nutrition
Choong Euvolaemic patients within 6 hours after elective surgery
if anticipated need for IV maintenance was > 24 hours
Uncorrected plasma sodium level abnormalities before
the end of surgery
Patients with known abnormalities of ADH secretion
Patients requiring volume resuscitation and/or vasoac-
tive infusions
Recent loop diuretic use
Total parenteral nutrition required with 24 hours fol-
lowing surgery
Patients for whom either a hypotonic or isotonic Iso-
tonic fluid was considered necessary or contraindicated
(e.g. because of a risk of cerebral oedema, acute burns
or the risk of third space and/or sodium overload in pa-
tients with pre-existing congestive cardiac failure, renal
failure, liver failure or cirrhosis)
Saba Patients requiring at least 8 hours of IV fluids Baseline Na of < 133 or > 145 mmol/L
Patients with any of renal disease, cardiac dysfunction,
pre-existing hypertension, diuretic use, oedema, known
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Table 4. Inclusion and exclusion criteria (Continued)
adrenal dysfunction, acute or severe chronic neurologi-
cal illness
Coulthard Patients admitted to PICU following spinal instrumen-
tation for correction of scoliosis, craniotomy for exci-
sion of brain tumours and cranial vault remodelling
Lengthening only of spinal instrumentation rods, inser-
tion or revision of ventriculoperitoneal shunts, intrac-
erebral cyst fenestration or previously enrolled
Cuello Patients 6 months to 14 years old; with a serum sodium
level between 125 mmol/L to 150 mmol/L; previously
healthy, admitted to the emergency room or hospitali-
sation ward with any of 2 conditions: a) gastroenteritis
with moderate dehydration and unable to drink fluids;
b) children undergoing non-urgent surgery and requir-
ing maintenance IV hydration during their hospitalisa-
tion (i.e. non-incarcerated hernia, adenotonsillectomies,
tympanostomy, fracture reductions of the extremities,
etc.)
Chronic illnesses (e.g. cystic fibrosis, cerebral palsy, etc.)
; taking antidiuretics; major trauma that required inten-
sive care; hyper or hyponatraemia at admission; severe
dehydration
ADH: antidiuretic hormone secretion
hr: hour
IV: intravenous
PICU: paediatric intensive care unit
A P P E N D I C E S
Appendix 1. Search strategies
Cochrane Injuries Group Specialised Register
((“fluid therap*”) or (“isotonic solution*”) or (“hypotonic solution*”) or (“fluid infusion*”) or (“sodium chloride”) or (electrolyte*
or hyponatremia or hyponatraemia) or (“ADH syndrome”) or ADH or (“antidiuretic hormone*”) or (“anti-diuretic hormone*”) or
(“brain edema*”) or (“brain oedema*”))
AND (child* or infan* or toddler* or pre-school* or preschool* or young* or adolesc* or pediat* or paediat* or minor* or boy* or girl*)
Cochrane Central Register of Controlled Trials (The Cochrane Library)
#1MeSH descriptor Fluid Therapy explode all trees
#2MeSH descriptor Isotonic Solutions explode all trees
#3MeSH descriptor Hypotonic Solutions explode all trees
#4MeSH descriptor Electrolytes explode all trees
#5MeSH descriptor Sodium Chloride explode all trees
#6infusion*
#7hypotonic or isotonic
#8(#1 OR #2 OR #3 OR #4 OR #5 OR #6 OR #7)
#9MeSH descriptor Hyponatremia explode all trees
#10MeSH descriptor Inappropriate ADH Syndrome explode all trees
#11MeSH descriptor Brain Edema explode all trees
#12Hyponatr*emia or brain oedema or brain edema or ADH or anti*diuretic hormone*
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#13(#9 OR #10 OR #11 OR #12)
#14(#8 AND #13)
MEDLINE (OvidSP)
1.exp fluid therapy/
2.exp isotonic solutions/
3.exp hypotonic solutions/
4.(hypotonic or isotonic).mp.
5.infusion.mp.
6.exp sodium chloride/
7.exp electrolytes/
8.1 or 2 or 3 or 4 or 5 or 6 or 7
9.exp hyponatremia/
10.hyponatraemia.mp.
11.exp inappropriate ADH syndrome/
12.(ADH or anti?diuretic hormone*).mp.
13.exp brain edema/
14.brain oedema.mp.
15.9 or 10 or 11 or 12 or 13 or 14
16.randomi?ed.ab,ti.
17.randomized controlled trial.pt.
18.controlled clinical trial.pt.
19.placebo.ab.
20.clinical trials as topic.sh.
21.randomly.ab.
22.trial.ti.
23.16 or 17 or 18 or 19 or 20 or 21 or 22
24.animals not (humans and animals).sh.
25.23 not 24.
26.8 and 15 and 25
ISI Web of Science: Science Citation Index Expanded (SCI-EXPANDED) & Conference Proceedings Citation Index-Science
(CPCI-S)
1.TS=((singl* OR doubl* OR trebl* OR tripl*) NEAR/3 (blind* ORmask*)) ORTS=((clinical OR control* OR placeboOR random*)
NEAR/3 (trial* or group* or study or studies or placebo or controlled))
2.TS=((fluid near/3 therap*) or (isotonic near/3 solution*) or (hypotonic near/3 solution*)) ORTS=((fluid near/3 infusion*) or (sodium
chloride) or electrolyte*)
3.TS=(hyponatremia or hyponatraemia) ORTS=((inappropriate ADH syndrome) or ADHor (antidiuretic hormone*) or (anti-diuretic
hormone*)) OR TS=((brain edema*) or (brain oedema*))
4.1 and 2 and 3
Embase (OvidSP)
1 exp fluid therapy/
2 exp isotonic solutions/
3 exp hypotonic solutions/
4 (hypotonic or isotonic).mp.
5 infusion.mp.
6 exp sodium chloride/
7 exp electrolytes/
8 1 or 2 or 3 or 4 or 5 or 6 or 7
9 exp hyponatremia/
10 hyponatraemia.mp.
11 exp inappropriate ADH syndrome/
12 (ADH or anti?diuretic hormone*).mp.
13 exp brain edema/
14 brain oedema.mp.
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15 9 or 10 or 11 or 12 or 13 or 14
16 exp Randomized Controlled Trial/
17 exp controlled clinical trial/
18 randomi?ed.ab,ti.
19 placebo.ab.
20 *Clinical Trial/
21 randomly.ab.
22 trial.ti.
23 16 or 17 or 18 or 19 or 20 or 21 or 22
24 exp animal/ not (exp human/ and exp animal/)
25 23 not 24
26 8 and 15 and 25
C O N T R I B U T I O N S O F A U T H O R S
Sarah McNab and Tavey Dorofaeff screened the titles and abstracts of all trials identified through the search for potential inclusion.
Two authors independently performed data extraction for each study (each author was involved with data extraction of at least one
study, with Sarah McNab involved with data extraction for each study).
The initial draft was written by Sarah McNab, with all authors contributing to draft revisions.
Robert Ware provided statistical advice and assistance.
D E C L A R A T I O N S O F I N T E R E S T
Sarah McNab, Trevor Duke and Andrew Davidson have been involved in the design and conduct of a trial (McNab 2014), which
would potentially be eligible for future revisions of this Cochrane Review.
Mark Coulthard, Robert Ware, Karen Choong and Kristen Neville were involved in the design and conduct of studies included in this
Cochrane Review. We did not extract outcome or quality data from the studies we co-author.
Tavey Dorofaeff: None known.
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Internal sources
• No sources of support supplied
External sources
• Murdoch Childrens Research Institute, Australia.
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• Vincent Fairfax Family Foundation Research Entry Scholarship, Royal Australasian College of Physicians, Australia.
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D I F F E R E N C E S B E TW E E N P R O T O C O L A N D R E V I E W
A secondary outcome planned in our protocol was mean change in serum sodium. We removed this due to doubts about the statistical
significance of this outcome, with concerns about false positive results when comparisons are made within randomised groups (Bland
2011). In addition, the clinical significance of change in sodium is complex and related to the initial sodium for an individual patient.
These data were not available.
We included two sensitivity analyses that were not described a priori: these are described in the main text. We did not conduct a
planned sensitivity analysis on allocation concealment as only one, small study did not conceal allocation. All subgroup analyses were
pre-specified in the protocol.
The protocol for this review initially stated that we would look to analyse continuous outcomes according to two time blocks: < 12
hours and ≥ 12 hours. Practically, when examining the available data in the included studies, this was difficult as, within individual
studies, there were multiple outcomes within the one time block. We elected to change the time blocks to 6 to 12 hours and > 12 to
24 hours. No study had more than one outcome reported within these time blocks. While some studies also reported outcomes in later
time blocks (e.g. T48 and T72), most had substantial drop-outs by this time frame with few meaningful data.
In the protocol, solutions with > or = 125 mmol/L of sodium were considered isotonic or near isotonic. In the review, we added an
upper limit of 160 mmol/L. For the subgroup analysis of moderately hypotonic fluid, the protocol defined moderately hypotonic fluid
as containing sodium of >/= 70 mmol/L and </= 100 mmol/L. We changed the latter to < 125 mmol/L in the review; this did not
affect the outcome as no study used fluid containing between 100 mmol/L and 125 mmol/L of sodium. We changed a restricted fluid
rate from </= 60% maintenance in the protocol to </= 70% of standard maintenance in the review.
The protocol stipulated that the rate at which fluid was administered would not be used to include or exclude studies. We removed this
from the final review for clarity. We did not use a predefined fluid rate to exclude studies; however, information on fluid rates assisted
in determining whether the fluid was being administered to maintain hydration, or for another purpose (e.g. for resuscitation or to
replace a pre-existing deficit).
I N D E X T E R M S
Medical Subject Headings (MeSH)
Fluid Therapy [∗adverse effects; methods]; Hypernatremia [blood; etiology]; Hyponatremia [blood; ∗etiology]; Hypotonic Solutions
[administration & dosage; ∗adverse effects]; Infusions, Intravenous; Isotonic Solutions [administration & dosage; ∗adverse effects];
Randomized Controlled Trials as Topic; Risk; Saline Solution, Hypertonic [administration & dosage; ∗adverse effects]; Sodium [blood]
MeSH check words
Adolescent; Child; Child, Preschool; Humans; Infant
60Isotonic versus hypotonic solutions for maintenance intravenous fluid administration in children (Review)
Copyright © 2014 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd.
